PIM3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14732 | S160 | Sugiyama | IMPA2 IMP.18P | RLYTGRRGRGAFCNGQRLRVsGETDLSKALVLTEIGPKRDP |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O60271 | S183 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | HTEMIHNYMEHLERTKLHQLsGsDQLEstAHsRIRKERPIs |
| O60271 | S190 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | YMEHLERTKLHQLsGsDQLEstAHsRIRKERPIsLGIFPLP |
| O60271 | S194 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | LERTKLHQLsGsDQLEstAHsRIRKERPIsLGIFPLPAGDG |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | S751 | Sugiyama | TBC1D4 AS160 KIAA0603 | EIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRIS |
| O60343 | S754 | Sugiyama | TBC1D4 AS160 KIAA0603 | QDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISWRQ |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O94761 | S27 | Sugiyama | RECQL4 RECQ4 | VRERLQAWERAFRRQRGRRPsQDDVEAAPEETRALYREYRT |
| O95155 | S23 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | ELSADEIRRRRLARLAGGQtsQPttPLtsPQRENPPGPPIA |
| O95639 | S267 | Sugiyama | CPSF4 CPSF30 NAR NEB1 | KCGEKGHYANRCTKGHLAFLsGQ__________________ |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95831 | S116 | Sugiyama | AIFM1 AIF PDCD8 | NERIsGLGLtPEQKQKKAALsAsEGEEVPQDKAPSHVPFLL |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | PSP|Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S319 | PSP | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00491 | S163 | Sugiyama | PNP NP | GQNPLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGE |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P01106 | S308 | PSP | MYC BHLHE39 | PGKRSESGSPSAGGHSKPPHsPLVLKRCHVSTHQHNYAAPP |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S12 | Sugiyama | LMNA LMN1 | _________METPsQRRAtRsGAQAsstPLsPtRItRLQEK |
| P02545 | S458 | Sugiyama | LMNA LMN1 | GRVAVEEVDEEGKFVRLRNKsNEDQsMGNWQIKRQNGDDPL |
| P02545 | T10 | Sugiyama | LMNA LMN1 | ___________METPsQRRAtRsGAQAsstPLsPtRItRLQ |
| P04040 | T28 | Sugiyama | CAT | ASDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRG |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S346 | Sugiyama | ALDOA ALDA | EEYVKRALANsLACQGKytPsGQAGAAAsEsLFVsNHAy__ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T65 | Sugiyama | ALDOA ALDA | QsIGtENtEENRRFyRQLLLtADDRVNPCIGGVILFHETLY |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S25 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | KVGVNGFGRIGRLVtRAAFNsGKVDIVAINDPFIDLNyMVY |
| P04406 | T19 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | __MGKVKVGVNGFGRIGRLVtRAAFNsGKVDIVAINDPFID |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S475 | Sugiyama | KRT8 CYK8 | TSSSRAVVVKKIETRDGKLVsEssDVLPK____________ |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07737 | S133 | Sugiyama | PFN1 | LMGKEGVHGGLINKKCyEMAsHLRRsQY_____________ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S470 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | HEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y466 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKE |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T487 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRKRG |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P09661 | S226 | Sugiyama | SNRPA1 | NAIANAstLAEVERLKGLLQsGQIPGRERRsGPtDDGEEEM |
| P09874 | S274 | Sugiyama | PARP1 ADPRT PPOL | KVCstNDLKELLIFNKQQVPsGEsAILDRVADGMVFGALLP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10809 | T422 | Sugiyama | HSPD1 HSP60 | AVLKVGGtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGC |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S432 | Sugiyama | IMPDH2 IMPD2 | RGMGsLDAMDKHLssQNRyFsEADKIKVAQGVsGAVQDKGS |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13674 | S387 | Sugiyama | P4HA1 P4HA | NPITGDLETVHYRISKsAWLsGyENPVVsRINMRIQDLTGL |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S67 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IICtIGPAsRsVEtLKEMIKsGMNVARLNFsHGtHEyHAEt |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S551 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEP |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14866 | S291 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | TRLNVFKNDQDtWDyTNPNLsGQGDPGsNPNKRQRQPPLLG |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15880 | S206 | Sugiyama | RPS2 RPS4 | GRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDCytsA |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17655 | S462 | Sugiyama | CAPN2 CANPL2 | GQTNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEY |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18206 | S820 | Sugiyama | VCL | DAKAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEP |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P21108 | S10 | Sugiyama | PRPS1L1 PRPS3 PRPSL | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P21108 | S8 | Sugiyama | PRPS1L1 PRPS3 PRPSL | _____________MPNIKIFsGssHQDLSQKIADRLGLELG |
| P21333 | S1301 | Sugiyama | FLNA FLN FLN1 | DARALtQtGGPHVKARVANPsGNLTEtyVQDRGDGMYKVEy |
| P22033 | S481 | Sugiyama | MMUT MUT | EGIPKLRIEECAARRQARIDsGSEVIVGVNKYQLEKEDAVE |
| P22059 | S379 | Sugiyama | OSBP OSBP1 | FFDAPEIITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLE |
| P22314 | S1020 | Sugiyama | UBA1 A1S9T UBE1 | FFMPAAKLKERLDQPMtEIVsRVSKRKLGRHVRALVLELCC |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | Y347 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MGGPyGGGNyGPGGsGGsGGyGGRsRy______________ |
| P23381 | S378 | Sugiyama | WARS1 IFI53 WARS WRS | sIFLtDtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDV |
| P23396 | T70 | Sugiyama | RPS3 OK/SW-cl.26 | ILATRTQNVLGEKGRRIRELtAVVQKRFGFPEGsVELyAEK |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P26038 | S144 | Sugiyama | MSN | LLASyAVQSKYGDFNKEVHKsGYLAGDKLLPQRVLEQHKLN |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26373 | S106 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | IHKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLIL |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26639 | S39 | Sugiyama | TARS1 TARS | PIGAGEEKQKEGGKKKNKEGsGDGGRAELNPWPEyIytRLE |
| P26641 | S25 | Sugiyama | EEF1G EF1G PRO1608 | TLyTyPENWRAFKALIAAQYsGAQVRVLsAPPHFHFGQtNR |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29401 | S473 | Sugiyama | TKT | AtEKAVELAANTKGICFIRTsRPENAIIyNNNEDFQVGQAK |
| P30041 | T49 | Sugiyama | PRDX6 AOP2 KIAA0106 | LGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKLI |
| P30043 | S198 | Sugiyama | BLVRB FLR SCAN | KHDLGHFMLRCLttDEyDGHstyPsHQyQ____________ |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30086 | S142 | Sugiyama | PEBP1 PBP PEBP | WLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyELRA |
| P30101 | S98 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | VPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGP |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P30876 | S882 | Sugiyama | POLR2B | GDDVIIGKTVtLPENEDELEstNRRYTKRDCSTFLRTSETG |
| P31327 | S819 | Sugiyama | CPS1 | MAIGRTFEEsFQKALRMCHPsIEGFTPRLPMNKEWPsNLDL |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31946 | S132 | Sugiyama | YWHAB | TQPESKVFyLKMKGDYFRyLsEVAsGDNKQTtVsNsQQAyQ |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32929 | S56 | Sugiyama | CTH | AVVPPISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVA |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35568 | S1101 | EPSD|PSP | IRS1 | RNQSAKVIRADPQGCRRRHssEtFsstPSATRVGNTVPFGA |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38606 | S125 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | PLSDISSQTQSIYIPRGVNVsALSRDIKWDFTPCKNLRVGS |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40227 | S49 | Sugiyama | CCT6A CCT6 CCTZ | GLQDVLRTNLGPKGTMKMLVsGAGDIKLTKDGNVLLHEMQI |
| P40429 | S44 | Sugiyama | RPL13A | AKQVLLGRKVVVVRCEGINIsGNFyRNKLKYLAFLRKRMNt |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P40925 | S153 | Sugiyama | MDH1 MDHA | ANtNCLtAsKSAPSIPKENFsCLtRLDHNRAKAQIALKLGV |
| P40939 | T418 | Sugiyama | HADHA HADH | DRGQQQVFKGLNDKVKKKALtSFERDSIFSNLTGQLDyQGF |
| P41091 | S282 | Sugiyama | EIF2S3 EIF2G | FDVNKPGCEVDDLKGGVAGGsILKGVLKVGQEIEVRPGIVS |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S299 | Sugiyama | MKI67 | GLQGETQLLVSRKSRPKsGGsGHAVAEPAsPEQELDQNKGK |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | S1997 | Sugiyama | FASN FAS | DGLLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFV |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | S603 | Sugiyama | FXR2 FMR1L2 | QRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsR |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51692 | S731 | PSP | STAT5B | FVNASADAGGGSATyMDQAPsPAVCPQAHyNMyPQNPDSVL |
| P52209 | S126 | Sugiyama | PGD PGDH | YRDTTRRCRDLKAKGILFVGsGVsGGEEGARyGPSLMPGGN |
| P52209 | S129 | Sugiyama | PGD PGDH | TTRRCRDLKAKGILFVGsGVsGGEEGARyGPSLMPGGNKEA |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55072 | S718 | Sugiyama | VCP HEL-220 HEL-S-70 | AIREsIEsEIRRERERQtNPsAMEVEEDDPVPEIRRDHFEE |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57721 | S59 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EGGLNVTLTIRLLMHGKEVGsIIGKKGETVKKMREESGARI |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P57721 | T159 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | sQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAVT |
| P57723 | S31 | Sugiyama | PCBP4 | EPELSITLTLRMLMHGKEVGsIIGKKGETVKRIREQSSARI |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60228 | S442 | Sugiyama | EIF3E EIF3S6 INT6 | IEKKLNQNSRSEAPNWAtQDsGFy_________________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P60891 | S10 | Sugiyama | PRPS1 | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P60891 | S8 | Sugiyama | PRPS1 | _____________MPNIKIFsGssHQDLSQKIADRLGLELG |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61254 | S23 | Sugiyama | RPL26 | FNPFVtsDRsKNRKRHFNAPsHIRRKIMssPLSKELRQKYN |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61769 | T106 | Sugiyama | B2M CDABP0092 HDCMA22P | YYTEFTPTEKDEYACRVNHVtLsQPKIVKWDRDM_______ |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S114 | Sugiyama | RPS14 PRO2640 | HIKLRATGGNRtKtPGPGAQsALRALARSGMKIGRIEDVtP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | S74 | Sugiyama | RPS11 | tyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIVIRRDYLH |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62753 | S148 | Sugiyama | RPS6 OK/SW-cl.2 | tVPRRLGPKRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKK |
| P62753 | S53 | Sugiyama | RPS6 OK/SW-cl.2 | AtEVAADALGEEWKGYVVRIsGGNDKQGFPMKQGVLTHGRV |
| P62805 | S48 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | QGItKPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIR |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62851 | S74 | Sugiyama | RPS25 | tyDKLCKEVPNYKLItPAVVsERLKIRGSLARAALQELLsK |
| P62888 | S75 | Sugiyama | RPL30 | LRKsEIEyyAMLAKtGVHHysGNNIELGtACGKyyRVCtLA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62910 | S105 | Sugiyama | RPL32 PP9932 | LEVLLMCNKsyCAEIAHNVSsKNRKAIVERAAQLAIRVTNP |
| P62913 | S51 | Sugiyama | RPL11 | DRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEKIAVH |
| P62913 | T44 | Sugiyama | RPL11 | ICVGEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRR |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68431 | T59 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| P78371 | S143 | Sugiyama | CCT2 99D8.1 CCTB | PQTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIA |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84243 | T59 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q04446 | T570 | Sugiyama | GBE1 | DFPRKGNNESYHYARRQFHLtDDDLLRYKFLNNFDRDMNRL |
| Q04695 | S32 | Sugiyama | KRT17 | SsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGLGSTL |
| Q04726 | S197 | Sugiyama | TLE3 KIAA1547 | HLTVKDEKNHHELDHREREssANNsVsPsEsLRAsEKHRGs |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07021 | S106 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | LsDEIKEERKIQKHKTLPKMsGGWELELNGTEAKLVRKVAG |
| Q08J23 | S593 | Sugiyama | NSUN2 SAKI TRM4 | NNSEKMKVINTGIKVWCRNNsGEEFDCAFRLAQEGIYTLYP |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09028 | S159 | Sugiyama | RBBP4 RBAP48 | IIATKtPssDVLVFDyTKHPsKPDPsGECNPDLRLRGHQKE |
| Q09028 | S164 | Sugiyama | RBBP4 RBAP48 | tPssDVLVFDyTKHPsKPDPsGECNPDLRLRGHQKEGYGLS |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q13200 | S361 | SIGNOR|PSP | PSMD2 TRAP2 | EPKVPDDIyKtHLENNRFGGsGsQVDSARMNLASSFVNGFV |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14152 | S215 | Sugiyama | EIF3A EIF3S10 KIAA0139 | RKLCDNLRMHLsQIQRHHNQstAINLNNPESQsMHLETRLV |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14566 | T195 | Sugiyama | MCM6 | TQPNICRNPVCANRRRFLLDtNKSRFVDFQKVRIQETQAEL |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | T112 | Sugiyama | PUM1 KIAA0099 PUMH1 | QLGGGGsGGGGyNNsKHRWPtGDNIHAEHQVRsMDELNHDF |
| Q14697 | S45 | Sugiyama | GANAB G2AN KIAA0088 | VCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPyRALLD |
| Q14697 | T40 | Sugiyama | GANAB G2AN KIAA0088 | LAFLGVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPy |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S13 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | ________MADFDtyDDRAyssFGGGRGsRGsAGGHGsRSQ |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15365 | S27 | Sugiyama | PCBP1 | ESGLNVTLTIRLLMHGKEVGsIIGKKGESVKRIREEsGARI |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15365 | T127 | Sugiyama | PCBP1 | TQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15366 | S27 | Sugiyama | PCBP2 | EGGLNVTLTIRLLMHGKEVGsIIGKKGESVKKMREESGARI |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15366 | T127 | Sugiyama | PCBP2 | sQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15599 | T102 | Sugiyama | NHERF2 SLC9A3R2 | QTRLLVVDQETDEELRRRQLtCTEEMAQRGLPPAHDPWEPK |
| Q15785 | S186 | Sugiyama | TOMM34 URCC3 | HKEMAKSKSKETTATKNRVPsAGDVEKARVLKEEGNELVKK |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16576 | S163 | Sugiyama | RBBP7 RBAP46 | tPssDVLVFDyTKHPAKPDPsGECNPDLRLRGHQKEGYGLS |
| Q16658 | S156 | Sugiyama | FSCN1 FAN1 HSN SNL | IAMHPQVNIYSVTRKRYAHLsARPADEIAVDRDVPWGVDSL |
| Q16658 | S234 | Sugiyama | FSCN1 FAN1 HSN SNL | LEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELF |
| Q16695 | T59 | Sugiyama | H3-4 H3FT HIST3H3 | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLMREIAQDF |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q2VIR3 | S282 | Sugiyama | EIF2S3B | FDVNKPGCEVDDLKGGVAGGsILKGVLKVGQETEVRPGIVS |
| Q3KQU3 | T118 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | PPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEVKKAGER |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | T263 | Sugiyama | HSP90AB2P HSP90BB | FSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWKRD |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5JSH3 | T746 | Sugiyama | WDR44 RPH11 | YHTQIHVRSTRGRNKVGRKItGIEPLPGENKILVTSNDSRI |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6IBS0 | S139 | Sugiyama | TWF2 PTK9L MSTP011 | DELFGTVKDDLSFAGyQKHLssCAAPAPLtsAERELQQIRI |
| Q6L8Q7 | S103 | Sugiyama | PDE12 | LKGHAKAAAAKKSRKsRPNAsGGAACSGPGPEPAVFCEPVV |
| Q6L8Q7 | S98 | Sugiyama | PDE12 | IATNALKGHAKAAAAKKSRKsRPNAsGGAACSGPGPEPAVF |
| Q6NXT2 | T58 | Sugiyama | H3-5 H3F3C | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UWE0 | S158 | Sugiyama | LRSAM1 TAL UNQ6496/PRO21356 | KLKELPDTVGELRSLRTLNIsGNEIQRLPQMLAHVRTLEML |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T59 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7L5Y9 | S226 | Sugiyama | MAEA EMP HLC10 PIG5 | IELIRQNKRLDAVRHARKHFsQAEGSQLDEVRQAMGMLAFP |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V86 | S182 | Sugiyama | PIM3 | HSCGVVHRDIKDENLLVDLRsGELKLIDFGSGALLKDTVyt |
| Q86V86 | S263 | Sugiyama | PIM3 | IPFEQDEEILRGRLLFRRRVsPECQQLIRWCLSLRPSERPS |
| Q86V86 | T202 | Sugiyama | PIM3 | sGELKLIDFGSGALLKDTVytDFDGtRVySPPEWIRYHRYH |
| Q86V86 | T207 | Sugiyama | PIM3 | LIDFGSGALLKDTVytDFDGtRVySPPEWIRYHRYHGRSAT |
| Q86V86 | Y201 | Sugiyama | PIM3 | RsGELKLIDFGSGALLKDTVytDFDGtRVySPPEWIRYHRY |
| Q86V86 | Y210 | Sugiyama | PIM3 | FGSGALLKDTVytDFDGtRVySPPEWIRYHRYHGRSATVWS |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IYE1 | S680 | Sugiyama | CCDC13 | LTTRLAIQVEENEMLKAALGsALRGKEEDFRMYHEILGQVK |
| Q8N1G4 | T27 | Sugiyama | LRRC47 KIAA1185 | SESWPELELAERERRRELLLtGPGLEERVRAAGGQLPPRLF |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N684 | S166 | Sugiyama | CPSF7 | PGKVLNGEKVDVRPAtRQNLsQFEAQARKRECVRVPRGGIP |
| Q8N806 | S411 | Sugiyama | UBR7 C14orf130 | ADEGTVVKREDIQQFFEEFQsKKRRRVDGMQYYCS______ |
| Q8NBP7 | S487 | Sugiyama | PCSK9 NARC1 PSEC0052 | PTRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKL |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TD16 | S658 | Sugiyama | BICD2 KIAA0699 | IKHLQAAVDRTTELSRQRIAsQELGPAVDKDKEALMEEILK |
| Q8TEW0 | S837 | Sugiyama | PARD3 PAR3 PAR3A | AFQREGFGRQsMsEKRtKQFsDAsQLDFVKTRKsKsMDLGI |
| Q8WUX9 | T408 | Sugiyama | CHMP7 | LQDTTKEPLDLPDNPRNRHFtNsVPNPRIsDAELEAELEKL |
| Q92597 | S326 | Sugiyama | NDRG1 CAP43 DRG1 RTP | KYFVQGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHt |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92734 | S50 | Sugiyama | TFG | DITyDELVLMMQRVFRGKLLsNDEVTIKYKDEDGDLITIFD |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q92785 | S151 | Sugiyama | DPF2 BAF45D REQ UBID4 | RGAPDPRVDDDsLGEFPVTNsRARKRILEPDDFLDDLDDED |
| Q92934 | S118 | SIGNOR|iPTMNet|EPSD | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S75 | SIGNOR|iPTMNet|EPSD|PSP | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | SIGNOR|iPTMNet|EPSD | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96E14 | S78 | Sugiyama | RMI2 C16orf75 | VWMQGRVVMADRGEARLRDPsGDFSVRGLERVPRGRPCLVP |
| Q96I99 | S98 | Sugiyama | SUCLG2 | KEIVLKAQILAGGRGKGVFNsGLKGGVHLTKDPNVVGQLAK |
| Q96N67 | S1432 | Sugiyama | DOCK7 KIAA1771 | RRSRGQLGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWR |
| Q96RE7 | S330 | Sugiyama | NACC1 BTBD14B NAC1 | MNVGQTAEKVEALPEQVAPEsRNRIRVRQDLASLPAELINQ |
| Q99613 | S638 | Sugiyama | EIF3C EIF3S8 | ICAFRQGLTKDAHNALLDIQssGRAKELLGQGLLLRSLQER |
| Q99729 | S242 | Sugiyama | HNRNPAB ABBP1 HNRPAB | SKCEIKVAQPKEVyQQQQyGsGGRGNRNRGNRGSGGGGGGG |
| Q99832 | S59 | Sugiyama | CCT7 CCTH NIP7-1 | TLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTL |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9H0A0 | S593 | Sugiyama | NAT10 ALP KIAA1709 | VLAVIQVCLEGEISRQSILNsLSRGKKASGDLIPWTVSEQF |
| Q9H3N1 | S226 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | LCPSKRRRPQPYPYPSKKLLsEsAQPLKKVEEEQEADEEDV |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NSE4 | S98 | Sugiyama | IARS2 | RQQPDtELEIQQKCGFSELysWQRERKVKTEFCLHDGPPYA |
| Q9NYV4 | S1053 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | LPHWQDCHELWSKKRRRQRQsGVVVEEPPPSKTSRKETtsG |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UJ70 | S76 | Sugiyama | NAGK | AKRKAGVDPLVPLRsLGLsLsGGDQEDAGRILIEELRDRFP |
| Q9UNN5 | S582 | Sugiyama | FAF1 UBXD12 UBXN3A CGI-03 | PPEPKEENAEPVSKLRIRtPsGEFLERRFLASNKLQIVFDF |
| Q9UQ35 | S2453 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | QAPsQsLLPPAQDQPRsPVPsAFsDQsRCLIAQTTPVAGSQ |
| Q9UQ80 | S267 | Sugiyama | PA2G4 EBP1 | YKRDPSKQYGLKMKtSRAFFsEVERRFDAMPFtLRAFEDEK |
| Q9UQ80 | S335 | Sugiyama | PA2G4 EBP1 | FVAQFKFTVLLMPNGPMRITsGPFEPDLyKsEMEVQDAELK |
| Q9UQ80 | T377 | Sugiyama | PA2G4 EBP1 | LLQssAsRKtQKKKKKKAsKtAENAtsGEtLEENEAGD___ |
| Q9Y262 | S249 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | NVLHSLVDKSNINRQLEVytsGGDPEsVAGEyGRHSLYKML |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2V2 | S52 | Sugiyama | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y2X7 | S592 | Sugiyama | GIT1 | PLLsCsQEGsRHtsKLsRHGsGADsDyENtQSGDPLLGLEG |
| Q9Y3F4 | S153 | Sugiyama | STRAP MAWD UNRIP | EAEPKEISGHTSGIKKALWCsEDKQILsADDKtVRLWDHAT |
| Q9Y3F4 | S254 | Sugiyama | STRAP MAWD UNRIP | EKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFS |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y697 | S283 | Sugiyama | NFS1 NIFS HUSSY-08 | KGVGAIYIRRRPRVRVEALQsGGGQERGMRsGTVPTPLVVG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.268144e-07 | 6.139 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.633971e-07 | 6.064 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.714405e-06 | 5.766 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.699016e-06 | 5.328 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.656503e-06 | 5.063 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.020112e-05 | 4.991 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.131791e-05 | 4.504 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.505132e-05 | 4.455 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.123383e-05 | 4.385 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.628088e-05 | 4.335 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.463736e-05 | 4.127 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.493880e-05 | 4.071 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.010141e-04 | 3.996 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.523628e-04 | 3.817 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.712452e-04 | 3.766 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.976223e-04 | 3.526 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.491815e-04 | 3.457 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.937420e-04 | 3.226 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.031255e-04 | 3.153 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.031255e-04 | 3.153 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.499176e-04 | 3.125 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.913956e-04 | 3.102 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.137582e-03 | 2.944 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.530670e-03 | 2.815 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.023604e-03 | 2.694 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.991136e-03 | 2.701 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.995861e-03 | 2.700 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.068732e-03 | 2.684 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.210681e-03 | 2.655 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.283315e-03 | 2.641 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.283315e-03 | 2.641 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.950899e-03 | 2.530 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.001954e-03 | 2.523 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.343632e-03 | 2.476 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.496060e-03 | 2.456 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.184283e-03 | 2.378 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.227135e-03 | 2.374 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.263976e-03 | 2.370 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.602219e-03 | 2.337 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.803086e-03 | 2.318 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.727392e-03 | 2.325 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.803086e-03 | 2.318 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.106396e-03 | 2.292 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.106396e-03 | 2.292 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.324577e-03 | 2.274 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.618540e-03 | 2.250 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.631479e-03 | 2.249 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.669487e-03 | 2.246 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.039962e-03 | 2.219 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 6.122524e-03 | 2.213 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.541118e-03 | 2.123 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.910483e-03 | 2.102 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.492415e-03 | 2.071 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.901807e-03 | 2.004 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.034251e-02 | 1.985 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.030995e-02 | 1.987 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.123534e-02 | 1.949 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.322587e-02 | 1.879 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.409254e-02 | 1.851 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.527796e-02 | 1.816 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.530358e-02 | 1.815 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.609486e-02 | 1.793 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.609486e-02 | 1.793 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.609486e-02 | 1.793 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.699808e-02 | 1.770 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.726071e-02 | 1.763 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.846418e-02 | 1.734 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.031077e-02 | 1.692 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.031077e-02 | 1.692 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.073287e-02 | 1.683 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.084618e-02 | 1.681 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.253460e-02 | 1.647 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.253460e-02 | 1.647 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.172838e-02 | 1.663 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.172838e-02 | 1.663 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.241133e-02 | 1.650 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.414363e-02 | 1.617 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.414363e-02 | 1.617 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.414363e-02 | 1.617 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.414363e-02 | 1.617 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.414363e-02 | 1.617 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.414363e-02 | 1.617 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.352771e-02 | 1.628 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.415811e-02 | 1.617 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.770699e-02 | 1.557 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.651657e-02 | 1.576 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.636266e-02 | 1.579 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.747435e-02 | 1.561 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.770699e-02 | 1.557 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 3.573220e-02 | 1.447 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.274043e-02 | 1.485 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.274043e-02 | 1.485 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.274043e-02 | 1.485 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.510991e-02 | 1.455 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.197690e-02 | 1.495 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.197690e-02 | 1.495 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.197690e-02 | 1.495 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.197690e-02 | 1.495 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.197690e-02 | 1.495 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.037071e-02 | 1.518 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.392582e-02 | 1.469 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.438439e-02 | 1.464 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.438439e-02 | 1.464 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.438439e-02 | 1.464 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.573220e-02 | 1.447 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.573220e-02 | 1.447 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.573220e-02 | 1.447 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.307058e-02 | 1.481 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.179608e-02 | 1.498 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.257281e-02 | 1.487 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.422110e-02 | 1.466 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.508760e-02 | 1.455 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.604598e-02 | 1.443 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.604598e-02 | 1.443 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.636291e-02 | 1.439 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.820347e-02 | 1.418 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.008013e-02 | 1.397 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.413941e-02 | 1.355 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.164945e-02 | 1.380 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.164945e-02 | 1.380 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.378508e-02 | 1.359 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.413941e-02 | 1.355 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.503812e-02 | 1.346 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.642799e-02 | 1.333 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.666215e-02 | 1.331 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.666215e-02 | 1.331 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.666215e-02 | 1.331 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.002012e-02 | 1.301 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.049067e-02 | 1.297 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.209804e-02 | 1.283 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.666974e-02 | 1.247 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.666974e-02 | 1.247 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.623466e-02 | 1.250 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.300850e-02 | 1.276 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.666974e-02 | 1.247 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.702639e-02 | 1.244 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.120710e-01 | 0.951 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.120710e-01 | 0.951 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.120710e-01 | 0.951 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.120710e-01 | 0.951 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.120710e-01 | 0.951 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.120710e-01 | 0.951 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.120710e-01 | 0.951 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.283010e-02 | 1.082 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.283010e-02 | 1.082 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.283010e-02 | 1.082 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.283010e-02 | 1.082 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.283010e-02 | 1.082 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.115880e-01 | 0.675 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.115880e-01 | 0.675 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.115880e-01 | 0.675 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.115880e-01 | 0.675 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.115880e-01 | 0.675 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.115880e-01 | 0.675 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.115880e-01 | 0.675 | 0 | 0 |
| Tandem pore domain halothane-inhibited K+ channel (THIK) | R-HSA-1299287 | 2.115880e-01 | 0.675 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.144600e-02 | 1.146 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.144600e-02 | 1.146 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.144600e-02 | 1.146 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.144600e-02 | 1.146 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.351475e-02 | 1.029 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.603732e-01 | 0.795 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.603732e-01 | 0.795 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.603732e-01 | 0.795 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.603732e-01 | 0.795 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.999565e-01 | 0.523 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.999565e-01 | 0.523 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.999565e-01 | 0.523 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.999565e-01 | 0.523 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.999565e-01 | 0.523 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.999565e-01 | 0.523 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.136313e-02 | 1.147 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.179955e-01 | 0.928 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.179955e-01 | 0.928 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.179955e-01 | 0.928 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.179955e-01 | 0.928 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.779991e-02 | 1.057 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.027474e-01 | 0.693 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.027474e-01 | 0.693 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.027474e-01 | 0.693 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.027474e-01 | 0.693 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.600640e-02 | 1.180 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.058862e-01 | 0.975 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.883901e-02 | 1.103 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.883901e-02 | 1.103 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.255050e-01 | 0.901 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.255050e-01 | 0.901 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.255050e-01 | 0.901 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.255050e-01 | 0.901 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.255050e-01 | 0.901 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.255050e-01 | 0.901 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.255050e-01 | 0.901 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.255050e-01 | 0.901 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.255050e-01 | 0.901 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.255050e-01 | 0.901 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.461734e-01 | 0.609 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.784248e-01 | 0.422 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.784248e-01 | 0.422 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.784248e-01 | 0.422 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.784248e-01 | 0.422 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.784248e-01 | 0.422 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.784248e-01 | 0.422 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.784248e-01 | 0.422 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.784248e-01 | 0.422 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.091567e-02 | 1.092 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.091567e-02 | 1.092 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.081649e-01 | 0.966 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.081649e-01 | 0.966 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.465216e-01 | 0.834 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.025294e-01 | 0.694 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.025294e-01 | 0.694 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.025294e-01 | 0.694 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.103622e-02 | 1.214 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.026904e-02 | 1.095 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.026904e-02 | 1.095 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.898836e-01 | 0.538 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.101672e-02 | 1.041 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.101672e-02 | 1.041 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.420223e-01 | 0.848 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.420223e-01 | 0.848 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.817700e-02 | 1.107 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.203470e-01 | 0.920 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.332767e-01 | 0.632 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.332767e-01 | 0.632 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.332767e-01 | 0.632 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.332767e-01 | 0.632 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.332767e-01 | 0.632 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.332767e-01 | 0.632 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.332767e-01 | 0.632 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.025303e-01 | 0.989 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.025303e-01 | 0.989 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.025303e-01 | 0.989 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.025303e-01 | 0.989 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.921495e-01 | 0.716 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.921495e-01 | 0.716 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.921495e-01 | 0.716 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.147944e-01 | 0.940 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.147944e-01 | 0.940 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.385299e-02 | 1.076 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.206805e-02 | 1.207 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.206805e-02 | 1.207 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.206805e-02 | 1.207 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.647766e-01 | 0.577 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.647766e-01 | 0.577 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.332692e-01 | 0.477 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.332692e-01 | 0.477 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.332692e-01 | 0.477 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.481017e-01 | 0.349 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.481017e-01 | 0.349 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.481017e-01 | 0.349 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.481017e-01 | 0.349 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.481017e-01 | 0.349 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.481017e-01 | 0.349 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.481017e-01 | 0.349 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.481017e-01 | 0.349 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.556398e-02 | 1.122 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.202046e-01 | 0.920 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.202046e-01 | 0.920 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.000139e-01 | 0.699 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.235522e-01 | 0.908 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.967409e-01 | 0.528 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.967409e-01 | 0.528 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.967409e-01 | 0.528 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.967409e-01 | 0.528 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.449411e-01 | 0.839 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.209121e-01 | 0.656 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.348231e-01 | 0.870 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.758541e-01 | 0.425 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.758541e-01 | 0.425 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.758541e-01 | 0.425 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.758541e-01 | 0.425 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.758541e-01 | 0.425 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.758541e-01 | 0.425 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.864749e-01 | 0.729 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.014968e-01 | 0.994 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.289068e-01 | 0.483 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.289068e-01 | 0.483 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.289068e-01 | 0.483 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.026423e-01 | 0.693 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.862585e-01 | 0.730 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.933257e-01 | 0.533 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.193235e-01 | 0.659 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.010447e-01 | 0.697 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.010447e-01 | 0.697 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.010447e-01 | 0.697 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.010447e-01 | 0.697 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.597114e-01 | 0.586 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.869564e-01 | 0.542 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.197687e-01 | 0.495 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.172731e-01 | 0.380 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.172731e-01 | 0.380 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.172731e-01 | 0.380 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.172731e-01 | 0.380 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.172731e-01 | 0.380 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.172731e-01 | 0.380 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.099716e-01 | 0.292 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.099716e-01 | 0.292 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.099716e-01 | 0.292 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.099716e-01 | 0.292 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.099716e-01 | 0.292 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.099716e-01 | 0.292 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.099716e-01 | 0.292 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.099716e-01 | 0.292 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 5.099716e-01 | 0.292 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.954211e-01 | 0.709 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.540391e-01 | 0.595 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.796027e-01 | 0.553 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.929246e-01 | 0.406 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.929246e-01 | 0.406 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.929246e-01 | 0.406 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.203036e-01 | 0.494 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.203036e-01 | 0.494 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.572525e-01 | 0.340 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.087542e-01 | 0.510 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.359589e-01 | 0.627 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.067260e-01 | 0.685 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.294613e-01 | 0.639 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.014244e-01 | 0.696 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.913085e-01 | 0.718 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.409787e-01 | 0.467 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.243838e-01 | 0.372 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.697498e-01 | 0.569 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.278445e-01 | 0.642 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.613821e-01 | 0.583 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.995703e-01 | 0.398 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.039052e-01 | 0.517 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.792268e-01 | 0.421 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.617831e-01 | 0.442 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.286784e-01 | 0.641 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.286784e-01 | 0.641 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.977006e-01 | 0.526 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.876895e-01 | 0.541 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.362709e-01 | 0.473 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.024413e-01 | 0.395 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.259188e-01 | 0.371 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.552580e-01 | 0.342 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.955947e-01 | 0.305 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.649089e-01 | 0.248 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.649089e-01 | 0.248 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.649089e-01 | 0.248 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.649089e-01 | 0.248 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.649089e-01 | 0.248 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.649089e-01 | 0.248 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.649089e-01 | 0.248 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.666909e-01 | 0.574 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.389647e-01 | 0.470 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.389647e-01 | 0.470 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.061235e-01 | 0.514 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.255515e-01 | 0.371 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.854482e-01 | 0.414 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.519621e-01 | 0.345 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.023623e-01 | 0.395 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.023623e-01 | 0.395 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.698335e-01 | 0.432 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.776087e-01 | 0.321 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.776087e-01 | 0.321 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.776087e-01 | 0.321 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.321646e-01 | 0.274 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.321646e-01 | 0.274 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.321646e-01 | 0.274 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.147403e-01 | 0.288 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.607036e-01 | 0.337 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.935577e-01 | 0.307 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.449123e-01 | 0.352 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.155805e-01 | 0.288 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.431474e-01 | 0.265 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.431474e-01 | 0.265 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.136900e-01 | 0.212 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.136900e-01 | 0.212 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.136900e-01 | 0.212 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.136900e-01 | 0.212 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.136900e-01 | 0.212 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.136900e-01 | 0.212 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.744120e-01 | 0.324 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.874081e-01 | 0.312 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.258821e-01 | 0.279 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.514077e-01 | 0.259 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.514077e-01 | 0.259 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.453584e-01 | 0.263 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.747567e-01 | 0.241 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.747567e-01 | 0.241 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.747567e-01 | 0.241 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.645830e-01 | 0.248 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.679600e-01 | 0.246 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.969370e-01 | 0.224 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.974019e-01 | 0.224 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.974019e-01 | 0.224 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.974019e-01 | 0.224 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.974019e-01 | 0.224 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.021049e-01 | 0.220 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.014886e-01 | 0.221 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.014886e-01 | 0.221 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.014886e-01 | 0.221 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.014886e-01 | 0.221 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.041180e-01 | 0.219 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.193439e-01 | 0.208 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.193090e-01 | 0.208 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.193090e-01 | 0.208 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.222273e-01 | 0.206 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.222273e-01 | 0.206 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.305926e-01 | 0.200 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.305926e-01 | 0.200 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.129253e-01 | 0.947 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.128137e-01 | 0.672 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.779900e-01 | 0.750 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.993806e-01 | 0.399 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.540391e-01 | 0.595 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.801006e-01 | 0.744 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.164786e-01 | 0.934 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.427019e-01 | 0.615 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.836232e-01 | 0.547 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.604764e-01 | 0.795 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.794848e-01 | 0.319 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.417772e-01 | 0.355 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.921495e-01 | 0.716 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.030318e-02 | 1.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.193090e-01 | 0.208 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.382561e-01 | 0.269 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.223061e-01 | 0.206 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.751217e-01 | 0.240 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.040634e-01 | 0.517 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.488971e-02 | 1.023 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.387314e-01 | 0.622 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.879229e-01 | 0.541 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.710744e-01 | 0.243 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 9.290611e-02 | 1.032 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.422298e-01 | 0.266 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.415110e-01 | 0.617 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.708657e-01 | 0.767 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.321646e-01 | 0.274 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.668775e-01 | 0.247 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.831900e-01 | 0.234 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.152115e-01 | 0.501 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.420223e-01 | 0.848 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.790128e-01 | 0.237 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.316416e-01 | 0.635 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.263791e-01 | 0.486 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.804872e-01 | 0.318 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.935112e-02 | 1.227 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.935577e-01 | 0.307 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.356448e-01 | 0.628 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.136313e-02 | 1.147 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.732488e-02 | 1.172 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.204553e-02 | 1.142 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.847871e-01 | 0.733 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.967409e-01 | 0.528 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.548972e-02 | 1.184 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.409351e-01 | 0.467 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.255515e-01 | 0.371 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.780257e-01 | 0.750 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.776588e-01 | 0.238 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.588066e-01 | 0.253 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.465216e-01 | 0.834 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.809774e-01 | 0.551 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.828321e-01 | 0.417 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.561023e-01 | 0.592 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.130988e-01 | 0.504 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 8.779991e-02 | 1.057 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.531046e-02 | 1.123 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.359394e-01 | 0.867 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.172731e-01 | 0.380 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.883112e-01 | 0.725 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.974019e-01 | 0.224 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.325868e-01 | 0.478 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.273974e-01 | 0.278 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.552580e-01 | 0.342 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.492806e-01 | 0.826 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.236230e-01 | 0.490 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.025294e-01 | 0.694 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.025294e-01 | 0.694 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.295272e-02 | 1.032 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.708657e-01 | 0.767 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.758541e-01 | 0.425 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.172731e-01 | 0.380 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.243838e-01 | 0.372 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.617831e-01 | 0.442 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.694611e-01 | 0.570 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.854138e-01 | 0.314 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.668775e-01 | 0.247 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.136900e-01 | 0.212 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.952055e-01 | 0.305 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.705643e-01 | 0.244 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.712723e-01 | 0.243 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.485510e-01 | 0.605 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.845269e-01 | 0.415 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.958810e-01 | 0.402 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.839526e-01 | 0.234 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.457113e-01 | 0.837 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.206805e-02 | 1.207 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.158008e-01 | 0.288 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.518847e-01 | 0.345 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.995703e-01 | 0.398 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.658321e-02 | 1.015 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.744276e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.036466e-01 | 0.394 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.967409e-01 | 0.528 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.041481e-02 | 1.152 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.758541e-01 | 0.425 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.211870e-01 | 0.655 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.172731e-01 | 0.380 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.172731e-01 | 0.380 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.649089e-01 | 0.248 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.263791e-01 | 0.486 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.604909e-01 | 0.584 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.744276e-01 | 0.324 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.136900e-01 | 0.212 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.996903e-01 | 0.222 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.132014e-01 | 0.290 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.132014e-01 | 0.290 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.974019e-01 | 0.224 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.193090e-01 | 0.208 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.169956e-01 | 0.380 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.798813e-01 | 0.237 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.242317e-01 | 0.205 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.766140e-01 | 0.753 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.031658e-01 | 0.518 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.847871e-01 | 0.733 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.164672e-01 | 0.287 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.173777e-01 | 0.286 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.417772e-01 | 0.355 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.364719e-01 | 0.626 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.313549e-02 | 1.031 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.026068e-01 | 0.989 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.709172e-02 | 1.113 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.617831e-01 | 0.442 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.027774e-01 | 0.299 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.668775e-01 | 0.247 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.668775e-01 | 0.247 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.859771e-01 | 0.313 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.572525e-01 | 0.340 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.524606e-01 | 0.258 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.209219e-01 | 0.376 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.539209e-01 | 0.451 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.881428e-01 | 0.231 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.911558e-01 | 0.309 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.348231e-01 | 0.870 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.077227e-01 | 0.968 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.418082e-01 | 0.617 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.418082e-01 | 0.617 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.934257e-01 | 0.533 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.461734e-01 | 0.609 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.332767e-01 | 0.632 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.332692e-01 | 0.477 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.758541e-01 | 0.425 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.758541e-01 | 0.425 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.864749e-01 | 0.729 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.610379e-01 | 0.442 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.172731e-01 | 0.380 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.172731e-01 | 0.380 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.929246e-01 | 0.406 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.730188e-01 | 0.428 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.387314e-01 | 0.622 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.649089e-01 | 0.248 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.649089e-01 | 0.248 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.649089e-01 | 0.248 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.255515e-01 | 0.371 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.899363e-01 | 0.538 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.854138e-01 | 0.314 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.567528e-01 | 0.448 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.129642e-01 | 0.384 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.859771e-01 | 0.313 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.371925e-01 | 0.270 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.453584e-01 | 0.263 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.705643e-01 | 0.244 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.784303e-01 | 0.555 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.784303e-01 | 0.555 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.109051e-01 | 0.214 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.359589e-01 | 0.627 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.391770e-01 | 0.470 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.193090e-01 | 0.208 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.719755e-01 | 0.565 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.934158e-01 | 0.533 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.526713e-01 | 0.453 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.948963e-01 | 0.226 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.437882e-01 | 0.353 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.556398e-02 | 1.122 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.172731e-01 | 0.380 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.686330e-01 | 0.329 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.818902e-01 | 0.235 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.479852e-01 | 0.606 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.224178e-01 | 0.492 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.899363e-01 | 0.538 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.206805e-02 | 1.207 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.483447e-01 | 0.348 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.259188e-01 | 0.371 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.153499e-02 | 1.211 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.224178e-01 | 0.492 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.557984e-01 | 0.449 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.758541e-01 | 0.425 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.610379e-01 | 0.442 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.099716e-01 | 0.292 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.854138e-01 | 0.314 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.828321e-01 | 0.417 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.168767e-01 | 0.380 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.305926e-01 | 0.200 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.170693e-01 | 0.380 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.718134e-01 | 0.326 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.871239e-02 | 1.231 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.791430e-02 | 1.009 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.722818e-01 | 0.764 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.093975e-01 | 0.215 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.526713e-01 | 0.453 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.147403e-01 | 0.288 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.258821e-01 | 0.279 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.264041e-01 | 0.279 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.557984e-01 | 0.449 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.519621e-01 | 0.345 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.335477e-01 | 0.477 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.150635e-01 | 0.667 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.089655e-01 | 0.388 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.027474e-01 | 0.693 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.058862e-01 | 0.975 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.197687e-01 | 0.495 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.274779e-01 | 0.369 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.738171e-02 | 1.012 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.864749e-01 | 0.729 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.103192e-01 | 0.677 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.854138e-01 | 0.314 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.921054e-01 | 0.407 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.531289e-01 | 0.597 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.295693e-01 | 0.639 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.182188e-01 | 0.209 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.793536e-01 | 0.554 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.563457e-01 | 0.448 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.776087e-01 | 0.321 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.423615e-01 | 0.466 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.457113e-01 | 0.837 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.277881e-01 | 0.894 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.566199e-01 | 0.448 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.686459e-01 | 0.433 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.182188e-01 | 0.209 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.455758e-01 | 0.610 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.318779e-01 | 0.635 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.010447e-01 | 0.697 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.026068e-01 | 0.989 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.060149e-01 | 0.296 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.057345e-01 | 0.976 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.318779e-01 | 0.635 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.318779e-01 | 0.635 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.404179e-01 | 0.267 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.217128e-01 | 0.375 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.735693e-02 | 1.241 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.215163e-01 | 0.655 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.587530e-02 | 1.018 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.603732e-01 | 0.795 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.999565e-01 | 0.523 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.999565e-01 | 0.523 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.027474e-01 | 0.693 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.728454e-01 | 0.762 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.461734e-01 | 0.609 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.784248e-01 | 0.422 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.784248e-01 | 0.422 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.420223e-01 | 0.848 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.921495e-01 | 0.716 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.647766e-01 | 0.577 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.647766e-01 | 0.577 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.481017e-01 | 0.349 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.481017e-01 | 0.349 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.758541e-01 | 0.425 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.424342e-01 | 0.615 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.289068e-01 | 0.483 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.439021e-02 | 1.128 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.919724e-01 | 0.717 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.572525e-01 | 0.340 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.572525e-01 | 0.340 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.572525e-01 | 0.340 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.243838e-01 | 0.372 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.995703e-01 | 0.398 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.955947e-01 | 0.305 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.955947e-01 | 0.305 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.649089e-01 | 0.248 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.946555e-01 | 0.531 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.484847e-01 | 0.348 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.321646e-01 | 0.274 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.147403e-01 | 0.288 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.012438e-01 | 0.397 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.964963e-01 | 0.402 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.155805e-01 | 0.288 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.668775e-01 | 0.247 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.136900e-01 | 0.212 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.136900e-01 | 0.212 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.136900e-01 | 0.212 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.136900e-01 | 0.212 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.136900e-01 | 0.212 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.514077e-01 | 0.259 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.974019e-01 | 0.224 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.222273e-01 | 0.206 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.425735e-01 | 0.465 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.517558e-01 | 0.258 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.985794e-01 | 0.223 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.734679e-01 | 0.428 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.154147e-01 | 0.382 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.709962e-01 | 0.567 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.751217e-01 | 0.240 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.172571e-01 | 0.380 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.521499e-01 | 0.345 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.540391e-01 | 0.595 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.790128e-01 | 0.237 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.539137e-01 | 0.343 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.883490e-01 | 0.540 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.883490e-01 | 0.540 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.003421e-01 | 0.301 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.305926e-01 | 0.200 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.851990e-01 | 0.414 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.496926e-01 | 0.603 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.572525e-01 | 0.340 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.409351e-01 | 0.467 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.951386e-01 | 0.530 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.719755e-01 | 0.565 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.504745e-01 | 0.346 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.510219e-01 | 0.821 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.510219e-01 | 0.821 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.776087e-01 | 0.321 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.088240e-01 | 0.216 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.762286e-01 | 0.425 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 1.716508e-01 | 0.765 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.203036e-01 | 0.494 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.514077e-01 | 0.259 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.887141e-01 | 0.230 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.353995e-01 | 0.628 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.233708e-02 | 1.035 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.464037e-01 | 0.460 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.031951e-01 | 0.220 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.062890e-01 | 0.974 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.101672e-02 | 1.041 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.921495e-01 | 0.716 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.552580e-01 | 0.342 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.026886e-01 | 0.693 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.675451e-01 | 0.776 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.524630e-02 | 1.069 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.000605e-02 | 1.097 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.758541e-01 | 0.425 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.172731e-01 | 0.380 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.172731e-01 | 0.380 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.172731e-01 | 0.380 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.003576e-01 | 0.698 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 4.552580e-01 | 0.342 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.649089e-01 | 0.248 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.752065e-01 | 0.560 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.136900e-01 | 0.212 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.136900e-01 | 0.212 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.996903e-01 | 0.222 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.305926e-01 | 0.200 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.305926e-01 | 0.200 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.686330e-01 | 0.329 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.686330e-01 | 0.329 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.969370e-01 | 0.224 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.969370e-01 | 0.224 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.854138e-01 | 0.314 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.854138e-01 | 0.314 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.431474e-01 | 0.265 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.596982e-01 | 0.338 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.332692e-01 | 0.477 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.402169e-01 | 0.619 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.996903e-01 | 0.222 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.998227e-01 | 0.523 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.025294e-01 | 0.694 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.298890e-01 | 0.367 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.933257e-01 | 0.533 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.644710e-01 | 0.248 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.996903e-01 | 0.222 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.041859e-01 | 0.690 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.200071e-01 | 0.921 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.999565e-01 | 0.523 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.999565e-01 | 0.523 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.027474e-01 | 0.693 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.784248e-01 | 0.422 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.420223e-01 | 0.848 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.481017e-01 | 0.349 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.099716e-01 | 0.292 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.099716e-01 | 0.292 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.929246e-01 | 0.406 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.617831e-01 | 0.442 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.649089e-01 | 0.248 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.649089e-01 | 0.248 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.649089e-01 | 0.248 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.006475e-01 | 0.522 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.036466e-01 | 0.394 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.136900e-01 | 0.212 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.996903e-01 | 0.222 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.969370e-01 | 0.224 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.193439e-01 | 0.208 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.985182e-01 | 0.702 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.604764e-01 | 0.795 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.559859e-01 | 0.449 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.995703e-01 | 0.398 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.263791e-01 | 0.486 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.704174e-01 | 0.431 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.496926e-01 | 0.603 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.463773e-01 | 0.460 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.136900e-01 | 0.212 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.996903e-01 | 0.222 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.481017e-01 | 0.349 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.147403e-01 | 0.288 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.613666e-01 | 0.336 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.151521e-01 | 0.211 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.850150e-01 | 0.314 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.027774e-01 | 0.299 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.935577e-01 | 0.307 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.200071e-01 | 0.921 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.027474e-01 | 0.693 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.784248e-01 | 0.422 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.784248e-01 | 0.422 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.758541e-01 | 0.425 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.649089e-01 | 0.248 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.322713e-01 | 0.364 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.136900e-01 | 0.212 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.136900e-01 | 0.212 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.003421e-01 | 0.301 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.996903e-01 | 0.222 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.167864e-01 | 0.210 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.728454e-01 | 0.762 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.259188e-01 | 0.371 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.955947e-01 | 0.305 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.921495e-01 | 0.716 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.481017e-01 | 0.349 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.172731e-01 | 0.380 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.955947e-01 | 0.305 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.649089e-01 | 0.248 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.136900e-01 | 0.212 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.222273e-01 | 0.206 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.636560e-01 | 0.249 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.933257e-01 | 0.533 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.147403e-01 | 0.288 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.164442e-01 | 0.665 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.136900e-01 | 0.212 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.136900e-01 | 0.212 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.885916e-01 | 0.230 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.414857e-01 | 0.849 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.649089e-01 | 0.248 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.699914e-01 | 0.432 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.668775e-01 | 0.247 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 4.552580e-01 | 0.342 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.556122e-01 | 0.341 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.305926e-01 | 0.200 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.305926e-01 | 0.200 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.393181e-01 | 0.268 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.331334e-01 | 0.273 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.404179e-01 | 0.267 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 2.933257e-01 | 0.533 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.259188e-01 | 0.371 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.352616e-01 | 0.197 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.367359e-01 | 0.196 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.367359e-01 | 0.196 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.367479e-01 | 0.196 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.375435e-01 | 0.195 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.377338e-01 | 0.195 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.404515e-01 | 0.194 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.404515e-01 | 0.194 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.404515e-01 | 0.194 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.430054e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.464102e-01 | 0.189 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.464102e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.464102e-01 | 0.189 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.464102e-01 | 0.189 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.464102e-01 | 0.189 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.504027e-01 | 0.187 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.524696e-01 | 0.185 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.530142e-01 | 0.185 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.536482e-01 | 0.185 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.536482e-01 | 0.185 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.561398e-01 | 0.183 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.561398e-01 | 0.183 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.561398e-01 | 0.183 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.570044e-01 | 0.182 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.570044e-01 | 0.182 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.570044e-01 | 0.182 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.570044e-01 | 0.182 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.570044e-01 | 0.182 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.570044e-01 | 0.182 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.570044e-01 | 0.182 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.570044e-01 | 0.182 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.570044e-01 | 0.182 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.592638e-01 | 0.181 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.596004e-01 | 0.181 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.596004e-01 | 0.181 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.596004e-01 | 0.181 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.596004e-01 | 0.181 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.596004e-01 | 0.181 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.596004e-01 | 0.181 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.596004e-01 | 0.181 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.596004e-01 | 0.181 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.608100e-01 | 0.180 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.657503e-01 | 0.177 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.677789e-01 | 0.175 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.677789e-01 | 0.175 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.677789e-01 | 0.175 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.694730e-01 | 0.174 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.694730e-01 | 0.174 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.694730e-01 | 0.174 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.694730e-01 | 0.174 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.700671e-01 | 0.174 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.739345e-01 | 0.171 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.751362e-01 | 0.171 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.785256e-01 | 0.168 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.803717e-01 | 0.167 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.803717e-01 | 0.167 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.803717e-01 | 0.167 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.859819e-01 | 0.164 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.867499e-01 | 0.163 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.867499e-01 | 0.163 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.867499e-01 | 0.163 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.867499e-01 | 0.163 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.867499e-01 | 0.163 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.867499e-01 | 0.163 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.867499e-01 | 0.163 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.867499e-01 | 0.163 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.867499e-01 | 0.163 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.867499e-01 | 0.163 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.867499e-01 | 0.163 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.867499e-01 | 0.163 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 6.867499e-01 | 0.163 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.867499e-01 | 0.163 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.900794e-01 | 0.161 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.902408e-01 | 0.161 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.911076e-01 | 0.160 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.911076e-01 | 0.160 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.911076e-01 | 0.160 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.914133e-01 | 0.160 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.914133e-01 | 0.160 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.914133e-01 | 0.160 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.922487e-01 | 0.160 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.954645e-01 | 0.158 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.954645e-01 | 0.158 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.954645e-01 | 0.158 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.954645e-01 | 0.158 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.954645e-01 | 0.158 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.954645e-01 | 0.158 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.954645e-01 | 0.158 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.954645e-01 | 0.158 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.954645e-01 | 0.158 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.954645e-01 | 0.158 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.954645e-01 | 0.158 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.954645e-01 | 0.158 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.954645e-01 | 0.158 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.954645e-01 | 0.158 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.971213e-01 | 0.157 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.971213e-01 | 0.157 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.971213e-01 | 0.157 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.971213e-01 | 0.157 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.971213e-01 | 0.157 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.971213e-01 | 0.157 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.991294e-01 | 0.155 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.991294e-01 | 0.155 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.013848e-01 | 0.154 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.013848e-01 | 0.154 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.018150e-01 | 0.154 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.074868e-01 | 0.150 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.120931e-01 | 0.147 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.120931e-01 | 0.147 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.120931e-01 | 0.147 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.120931e-01 | 0.147 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.122375e-01 | 0.147 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.148297e-01 | 0.146 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.148297e-01 | 0.146 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.170817e-01 | 0.144 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.170817e-01 | 0.144 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.170817e-01 | 0.144 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.171843e-01 | 0.144 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.235659e-01 | 0.141 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.247181e-01 | 0.140 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.288584e-01 | 0.137 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.296141e-01 | 0.137 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.296141e-01 | 0.137 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.296141e-01 | 0.137 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.296141e-01 | 0.137 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.296141e-01 | 0.137 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.296141e-01 | 0.137 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.296141e-01 | 0.137 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.296141e-01 | 0.137 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.296141e-01 | 0.137 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.296141e-01 | 0.137 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.296141e-01 | 0.137 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.296141e-01 | 0.137 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.296141e-01 | 0.137 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.296141e-01 | 0.137 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.296141e-01 | 0.137 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.306352e-01 | 0.136 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.306352e-01 | 0.136 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.319598e-01 | 0.136 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.319598e-01 | 0.136 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.319598e-01 | 0.136 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.319598e-01 | 0.136 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.328936e-01 | 0.135 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.328936e-01 | 0.135 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.342315e-01 | 0.134 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.342315e-01 | 0.134 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.342315e-01 | 0.134 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.342315e-01 | 0.134 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.348967e-01 | 0.134 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.356937e-01 | 0.133 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.356937e-01 | 0.133 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.356937e-01 | 0.133 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.356937e-01 | 0.133 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.356937e-01 | 0.133 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.388480e-01 | 0.131 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.388480e-01 | 0.131 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.388480e-01 | 0.131 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.505861e-01 | 0.125 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.505861e-01 | 0.125 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.505861e-01 | 0.125 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.505861e-01 | 0.125 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.505861e-01 | 0.125 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.506007e-01 | 0.125 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.506007e-01 | 0.125 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.506007e-01 | 0.125 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.506007e-01 | 0.125 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.535015e-01 | 0.123 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.535015e-01 | 0.123 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.567524e-01 | 0.121 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.576237e-01 | 0.121 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.576237e-01 | 0.121 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.576237e-01 | 0.121 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.576237e-01 | 0.121 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.576237e-01 | 0.121 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.599360e-01 | 0.119 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.599360e-01 | 0.119 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.599360e-01 | 0.119 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.599360e-01 | 0.119 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.599360e-01 | 0.119 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.599360e-01 | 0.119 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.599360e-01 | 0.119 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.599360e-01 | 0.119 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.599360e-01 | 0.119 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.599360e-01 | 0.119 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.627875e-01 | 0.118 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.661563e-01 | 0.116 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.661563e-01 | 0.116 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.681000e-01 | 0.115 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.681861e-01 | 0.115 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.681861e-01 | 0.115 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.681861e-01 | 0.115 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.681861e-01 | 0.115 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.691726e-01 | 0.114 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.692319e-01 | 0.114 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.706091e-01 | 0.113 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.706091e-01 | 0.113 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.779609e-01 | 0.109 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.779609e-01 | 0.109 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.779609e-01 | 0.109 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.779609e-01 | 0.109 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.809562e-01 | 0.107 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.809562e-01 | 0.107 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.809562e-01 | 0.107 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.829033e-01 | 0.106 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.844316e-01 | 0.105 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.847460e-01 | 0.105 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.847460e-01 | 0.105 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.847460e-01 | 0.105 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.858812e-01 | 0.105 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.859558e-01 | 0.105 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.868591e-01 | 0.104 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.868591e-01 | 0.104 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.868591e-01 | 0.104 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.868591e-01 | 0.104 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.868591e-01 | 0.104 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.868591e-01 | 0.104 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.868591e-01 | 0.104 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.868591e-01 | 0.104 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.868591e-01 | 0.104 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.937555e-01 | 0.100 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.937555e-01 | 0.100 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.950024e-01 | 0.100 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.959472e-01 | 0.099 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.967868e-01 | 0.099 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.967868e-01 | 0.099 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.967868e-01 | 0.099 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.967868e-01 | 0.099 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.968861e-01 | 0.099 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.003138e-01 | 0.097 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.083139e-01 | 0.092 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.083139e-01 | 0.092 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.083139e-01 | 0.092 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.083139e-01 | 0.092 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.083139e-01 | 0.092 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.096565e-01 | 0.092 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.107642e-01 | 0.091 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.107642e-01 | 0.091 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.107642e-01 | 0.091 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.107642e-01 | 0.091 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.107642e-01 | 0.091 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.107642e-01 | 0.091 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.107642e-01 | 0.091 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.107642e-01 | 0.091 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.107642e-01 | 0.091 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.141551e-01 | 0.089 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.141844e-01 | 0.089 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.141844e-01 | 0.089 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.141844e-01 | 0.089 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.141844e-01 | 0.089 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.141844e-01 | 0.089 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.141844e-01 | 0.089 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.141844e-01 | 0.089 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.141844e-01 | 0.089 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.149258e-01 | 0.089 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.149258e-01 | 0.089 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.149258e-01 | 0.089 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.156337e-01 | 0.089 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.209115e-01 | 0.086 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.209115e-01 | 0.086 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.209115e-01 | 0.086 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.271010e-01 | 0.082 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.286199e-01 | 0.082 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.286680e-01 | 0.082 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.302372e-01 | 0.081 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.302372e-01 | 0.081 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.302372e-01 | 0.081 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.302372e-01 | 0.081 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.302372e-01 | 0.081 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.319894e-01 | 0.080 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.319894e-01 | 0.080 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.319894e-01 | 0.080 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.319894e-01 | 0.080 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.319894e-01 | 0.080 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.319894e-01 | 0.080 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.321423e-01 | 0.080 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.328177e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.328177e-01 | 0.079 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.328177e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.328177e-01 | 0.079 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.328177e-01 | 0.079 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.328177e-01 | 0.079 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.328177e-01 | 0.079 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.342853e-01 | 0.079 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.364203e-01 | 0.078 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.391813e-01 | 0.076 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.391813e-01 | 0.076 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.414354e-01 | 0.075 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.414354e-01 | 0.075 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.414354e-01 | 0.075 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.427487e-01 | 0.074 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.440559e-01 | 0.074 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.440559e-01 | 0.074 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.450280e-01 | 0.073 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.450280e-01 | 0.073 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.450280e-01 | 0.073 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.450280e-01 | 0.073 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.452442e-01 | 0.073 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.452860e-01 | 0.073 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.474898e-01 | 0.072 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.508351e-01 | 0.070 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.508351e-01 | 0.070 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.508351e-01 | 0.070 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.508351e-01 | 0.070 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.508351e-01 | 0.070 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.508351e-01 | 0.070 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.508351e-01 | 0.070 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.508351e-01 | 0.070 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.508351e-01 | 0.070 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.508351e-01 | 0.070 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.508351e-01 | 0.070 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.508351e-01 | 0.070 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.508351e-01 | 0.070 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.508351e-01 | 0.070 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.508351e-01 | 0.070 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.508351e-01 | 0.070 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.508351e-01 | 0.070 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.534124e-01 | 0.069 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.534124e-01 | 0.069 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.546505e-01 | 0.068 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.546505e-01 | 0.068 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.586171e-01 | 0.066 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.586379e-01 | 0.066 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.586379e-01 | 0.066 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.586379e-01 | 0.066 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.610019e-01 | 0.065 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.618017e-01 | 0.065 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.645913e-01 | 0.063 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.645913e-01 | 0.063 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.645913e-01 | 0.063 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.646266e-01 | 0.063 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.646266e-01 | 0.063 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.675678e-01 | 0.062 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.675678e-01 | 0.062 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.675678e-01 | 0.062 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.675678e-01 | 0.062 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.675678e-01 | 0.062 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.675678e-01 | 0.062 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.675678e-01 | 0.062 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.675678e-01 | 0.062 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.675678e-01 | 0.062 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.675678e-01 | 0.062 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.675678e-01 | 0.062 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.675678e-01 | 0.062 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.675678e-01 | 0.062 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.675678e-01 | 0.062 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.675740e-01 | 0.062 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.683618e-01 | 0.061 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.692352e-01 | 0.061 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.695212e-01 | 0.061 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.711455e-01 | 0.060 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.711455e-01 | 0.060 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.711455e-01 | 0.060 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.711455e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.740096e-01 | 0.058 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.740096e-01 | 0.058 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.740096e-01 | 0.058 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.740096e-01 | 0.058 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.746407e-01 | 0.058 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.748621e-01 | 0.058 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.750126e-01 | 0.058 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.750126e-01 | 0.058 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.752178e-01 | 0.058 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.754007e-01 | 0.058 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.760472e-01 | 0.057 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.768117e-01 | 0.057 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.795927e-01 | 0.056 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.821383e-01 | 0.054 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.824244e-01 | 0.054 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.824244e-01 | 0.054 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.824244e-01 | 0.054 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.824244e-01 | 0.054 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.824244e-01 | 0.054 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.824244e-01 | 0.054 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.824244e-01 | 0.054 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.824244e-01 | 0.054 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.824244e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.826270e-01 | 0.054 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.826270e-01 | 0.054 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.826270e-01 | 0.054 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.826270e-01 | 0.054 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.826270e-01 | 0.054 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.826270e-01 | 0.054 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.826270e-01 | 0.054 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.828251e-01 | 0.054 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.828251e-01 | 0.054 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.828251e-01 | 0.054 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.838943e-01 | 0.054 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.847161e-01 | 0.053 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.868897e-01 | 0.052 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.879942e-01 | 0.052 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.882445e-01 | 0.051 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.931550e-01 | 0.049 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.931550e-01 | 0.049 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.931550e-01 | 0.049 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.937414e-01 | 0.049 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.937414e-01 | 0.049 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.937414e-01 | 0.049 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.937414e-01 | 0.049 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.956151e-01 | 0.048 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.956151e-01 | 0.048 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.956151e-01 | 0.048 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.956151e-01 | 0.048 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.956151e-01 | 0.048 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.956151e-01 | 0.048 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.956151e-01 | 0.048 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.956151e-01 | 0.048 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.956151e-01 | 0.048 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.956151e-01 | 0.048 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.961610e-01 | 0.048 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.987462e-01 | 0.046 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.027021e-01 | 0.044 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.027989e-01 | 0.044 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.027989e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.027989e-01 | 0.044 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.027989e-01 | 0.044 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.033321e-01 | 0.044 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.065663e-01 | 0.043 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.065663e-01 | 0.043 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.073266e-01 | 0.042 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.073266e-01 | 0.042 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.073266e-01 | 0.042 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.073266e-01 | 0.042 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.073266e-01 | 0.042 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.073266e-01 | 0.042 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.073266e-01 | 0.042 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.086827e-01 | 0.042 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.098634e-01 | 0.041 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.099097e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.099097e-01 | 0.041 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.116246e-01 | 0.040 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.116246e-01 | 0.040 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.116246e-01 | 0.040 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.116246e-01 | 0.040 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.117942e-01 | 0.040 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.117942e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.129201e-01 | 0.040 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.163085e-01 | 0.038 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.164353e-01 | 0.038 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.164353e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.171265e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.171265e-01 | 0.038 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.171265e-01 | 0.038 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.171265e-01 | 0.038 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.175511e-01 | 0.037 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.175511e-01 | 0.037 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.177248e-01 | 0.037 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.177248e-01 | 0.037 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.177248e-01 | 0.037 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.177248e-01 | 0.037 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.177248e-01 | 0.037 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.177248e-01 | 0.037 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.177248e-01 | 0.037 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.177248e-01 | 0.037 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.177248e-01 | 0.037 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.177248e-01 | 0.037 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.177248e-01 | 0.037 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.177248e-01 | 0.037 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.177248e-01 | 0.037 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.177248e-01 | 0.037 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.177248e-01 | 0.037 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.177469e-01 | 0.037 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.196941e-01 | 0.036 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.196941e-01 | 0.036 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.212304e-01 | 0.036 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.238121e-01 | 0.034 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.238121e-01 | 0.034 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.238121e-01 | 0.034 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.238121e-01 | 0.034 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.238121e-01 | 0.034 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.238121e-01 | 0.034 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.250119e-01 | 0.034 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.252137e-01 | 0.034 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.252137e-01 | 0.034 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.269568e-01 | 0.033 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.269568e-01 | 0.033 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.269568e-01 | 0.033 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.269568e-01 | 0.033 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.269568e-01 | 0.033 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.269568e-01 | 0.033 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.269568e-01 | 0.033 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.269568e-01 | 0.033 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.269568e-01 | 0.033 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.269568e-01 | 0.033 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.269568e-01 | 0.033 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.270661e-01 | 0.033 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.270661e-01 | 0.033 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.270661e-01 | 0.033 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.275113e-01 | 0.033 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.287878e-01 | 0.032 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.300001e-01 | 0.032 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.307549e-01 | 0.031 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.325979e-01 | 0.030 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.328108e-01 | 0.030 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.337954e-01 | 0.030 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.337954e-01 | 0.030 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.337954e-01 | 0.030 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.337954e-01 | 0.030 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.339235e-01 | 0.030 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.341797e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.351534e-01 | 0.029 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.351534e-01 | 0.029 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.351534e-01 | 0.029 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.351534e-01 | 0.029 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.351534e-01 | 0.029 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.351534e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.351534e-01 | 0.029 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.351534e-01 | 0.029 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.351534e-01 | 0.029 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.357225e-01 | 0.029 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.357225e-01 | 0.029 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.361370e-01 | 0.029 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.371989e-01 | 0.028 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.397091e-01 | 0.027 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.399334e-01 | 0.027 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.399334e-01 | 0.027 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.399334e-01 | 0.027 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.407367e-01 | 0.027 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.413303e-01 | 0.026 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.424306e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.424306e-01 | 0.026 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.424306e-01 | 0.026 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.424306e-01 | 0.026 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.424306e-01 | 0.026 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.424306e-01 | 0.026 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.424306e-01 | 0.026 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.424306e-01 | 0.026 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.424306e-01 | 0.026 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.427361e-01 | 0.026 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.427361e-01 | 0.026 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.427361e-01 | 0.026 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.452193e-01 | 0.024 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.455281e-01 | 0.024 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.458919e-01 | 0.024 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.473323e-01 | 0.023 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.478903e-01 | 0.023 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.483938e-01 | 0.023 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.488915e-01 | 0.023 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.488915e-01 | 0.023 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.488915e-01 | 0.023 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.488915e-01 | 0.023 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.488915e-01 | 0.023 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.488915e-01 | 0.023 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.503958e-01 | 0.022 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.505146e-01 | 0.022 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.506239e-01 | 0.022 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.506239e-01 | 0.022 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.506239e-01 | 0.022 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.523057e-01 | 0.021 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.532667e-01 | 0.021 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.545479e-01 | 0.020 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.545479e-01 | 0.020 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.546277e-01 | 0.020 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.546277e-01 | 0.020 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.546277e-01 | 0.020 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.546277e-01 | 0.020 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.546277e-01 | 0.020 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.546277e-01 | 0.020 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.546277e-01 | 0.020 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.546277e-01 | 0.020 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.546277e-01 | 0.020 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.552625e-01 | 0.020 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.552625e-01 | 0.020 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.552625e-01 | 0.020 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.552625e-01 | 0.020 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.552625e-01 | 0.020 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.552625e-01 | 0.020 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.552625e-01 | 0.020 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.572081e-01 | 0.019 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.574792e-01 | 0.019 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.583730e-01 | 0.018 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.589041e-01 | 0.018 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.594822e-01 | 0.018 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.594822e-01 | 0.018 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.597204e-01 | 0.018 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.597204e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.602123e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.603056e-01 | 0.018 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.631962e-01 | 0.016 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.633145e-01 | 0.016 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.633186e-01 | 0.016 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.633186e-01 | 0.016 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.633186e-01 | 0.016 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.639059e-01 | 0.016 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.642417e-01 | 0.016 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.642417e-01 | 0.016 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.642417e-01 | 0.016 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.642417e-01 | 0.016 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.642417e-01 | 0.016 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.642417e-01 | 0.016 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.649588e-01 | 0.015 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.651342e-01 | 0.015 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.657074e-01 | 0.015 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.658921e-01 | 0.015 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.661907e-01 | 0.015 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.661907e-01 | 0.015 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.661907e-01 | 0.015 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.668046e-01 | 0.015 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.668046e-01 | 0.015 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.668046e-01 | 0.015 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.671742e-01 | 0.014 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.679099e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.682557e-01 | 0.014 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.682557e-01 | 0.014 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.682557e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.682557e-01 | 0.014 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.682557e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.682557e-01 | 0.014 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.682557e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.682557e-01 | 0.014 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.684047e-01 | 0.014 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.688122e-01 | 0.014 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.699704e-01 | 0.013 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.699704e-01 | 0.013 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.699704e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.699704e-01 | 0.013 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.708122e-01 | 0.013 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.708501e-01 | 0.013 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.708501e-01 | 0.013 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.713236e-01 | 0.013 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.718194e-01 | 0.012 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.718194e-01 | 0.012 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.718194e-01 | 0.012 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.718194e-01 | 0.012 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.719935e-01 | 0.012 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.728375e-01 | 0.012 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.728441e-01 | 0.012 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.728441e-01 | 0.012 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.733636e-01 | 0.012 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.733636e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.738481e-01 | 0.012 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.746848e-01 | 0.011 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.749832e-01 | 0.011 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.749832e-01 | 0.011 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.749832e-01 | 0.011 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.749832e-01 | 0.011 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.749832e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.749832e-01 | 0.011 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.750038e-01 | 0.011 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.754512e-01 | 0.011 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.754512e-01 | 0.011 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.756706e-01 | 0.011 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.756706e-01 | 0.011 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.756706e-01 | 0.011 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.762178e-01 | 0.010 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.777867e-01 | 0.010 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.777867e-01 | 0.010 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.777919e-01 | 0.010 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.777919e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.777919e-01 | 0.010 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.777919e-01 | 0.010 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.778154e-01 | 0.010 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.793403e-01 | 0.009 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.794765e-01 | 0.009 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.797267e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.799584e-01 | 0.009 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.802855e-01 | 0.009 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.802855e-01 | 0.009 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.802855e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.802855e-01 | 0.009 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.802855e-01 | 0.009 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.802855e-01 | 0.009 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.802855e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.814461e-01 | 0.008 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.819000e-01 | 0.008 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.819000e-01 | 0.008 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.820544e-01 | 0.008 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.822629e-01 | 0.008 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.824992e-01 | 0.008 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.827951e-01 | 0.008 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.831297e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.831325e-01 | 0.007 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.836584e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.840519e-01 | 0.007 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.840980e-01 | 0.007 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.844302e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.844644e-01 | 0.007 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.844644e-01 | 0.007 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.844644e-01 | 0.007 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.844644e-01 | 0.007 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.844644e-01 | 0.007 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.846635e-01 | 0.007 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.852503e-01 | 0.006 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.852503e-01 | 0.006 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.859866e-01 | 0.006 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.859866e-01 | 0.006 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.862091e-01 | 0.006 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.862091e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.862091e-01 | 0.006 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.866908e-01 | 0.006 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.866908e-01 | 0.006 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.866908e-01 | 0.006 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.872166e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.872338e-01 | 0.006 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.877579e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.877579e-01 | 0.005 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.877579e-01 | 0.005 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.879939e-01 | 0.005 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.887425e-01 | 0.005 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.887425e-01 | 0.005 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.887457e-01 | 0.005 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.890347e-01 | 0.005 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.891329e-01 | 0.005 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.891329e-01 | 0.005 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.891329e-01 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.891450e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.894157e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.902376e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.912002e-01 | 0.004 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.912002e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.912013e-01 | 0.004 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.912100e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.913435e-01 | 0.004 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.914370e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.914370e-01 | 0.004 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.914370e-01 | 0.004 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.914370e-01 | 0.004 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.914428e-01 | 0.004 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.919105e-01 | 0.004 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.923989e-01 | 0.003 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.923989e-01 | 0.003 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.923989e-01 | 0.003 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.927462e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.928464e-01 | 0.003 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.928552e-01 | 0.003 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.931551e-01 | 0.003 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.932528e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.932528e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.932528e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.932528e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.934950e-01 | 0.003 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.935642e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.939749e-01 | 0.003 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.940109e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.940109e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.940109e-01 | 0.003 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.940109e-01 | 0.003 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.940864e-01 | 0.003 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.942977e-01 | 0.002 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.946838e-01 | 0.002 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.946838e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.946838e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.946838e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.946838e-01 | 0.002 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.950956e-01 | 0.002 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.952773e-01 | 0.002 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.953025e-01 | 0.002 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.953602e-01 | 0.002 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.953909e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.953909e-01 | 0.002 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.953909e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.954779e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.955145e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.955145e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.955145e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.956025e-01 | 0.002 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.957132e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.957723e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.958114e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.958114e-01 | 0.002 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.958316e-01 | 0.002 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.958642e-01 | 0.002 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.959283e-01 | 0.002 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.962820e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.962820e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.963625e-01 | 0.002 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.966284e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.968007e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.969216e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.969216e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.969908e-01 | 0.001 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.970017e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.972316e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.972316e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.972316e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.974000e-01 | 0.001 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.975108e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.975108e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.976600e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.976922e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.976922e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.977024e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.977336e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.977336e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.977844e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.978489e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.979516e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.979516e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.981819e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.981819e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.982401e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.982760e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.983144e-01 | 0.001 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.983686e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.985407e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.985677e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.985677e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986892e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.987220e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.987220e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.988227e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.988717e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.988717e-01 | 0.000 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.988791e-01 | 0.000 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.988851e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.989979e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.990508e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.990508e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.990763e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.991112e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.991112e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.991233e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.993755e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.993800e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994473e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.994491e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.995105e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.995656e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.996266e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996422e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.996511e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.996511e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.996578e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.996578e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.996578e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.996963e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997481e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.997536e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997730e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997780e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997877e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998328e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998509e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.998683e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998683e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.998874e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999040e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999080e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999183e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999357e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999409e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999429e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999475e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999494e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999494e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999611e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999646e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999720e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999751e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999753e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999773e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999783e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999827e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999854e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999863e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999879e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999911e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999921e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999931e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999959e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999971e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999977e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999979e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999980e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999988e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999989e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999990e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999995e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999995e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999996e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.330669e-16 | 15.477 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.661338e-16 | 15.176 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.221245e-15 | 14.913 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.442491e-15 | 14.612 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.662937e-15 | 14.331 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.440093e-15 | 14.264 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.326673e-15 | 14.080 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.396483e-14 | 13.357 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.714806e-13 | 12.430 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.829470e-13 | 12.316 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.563328e-13 | 12.255 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.787593e-13 | 12.238 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.692247e-13 | 12.014 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.035505e-12 | 11.985 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.060818e-12 | 11.974 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.270428e-12 | 11.896 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.247780e-12 | 11.904 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.780354e-12 | 11.749 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.730949e-12 | 11.762 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.164269e-12 | 11.665 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.331446e-12 | 11.477 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.555112e-12 | 11.255 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.873413e-12 | 11.231 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.110890e-12 | 11.214 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.235346e-12 | 11.205 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.418732e-12 | 11.130 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.119815e-11 | 10.951 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.186407e-11 | 10.926 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.270473e-11 | 10.896 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.259637e-11 | 10.900 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.259637e-11 | 10.900 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.492340e-11 | 10.826 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.478850e-11 | 10.830 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.967537e-11 | 10.528 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.020983e-11 | 10.520 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.669931e-11 | 10.435 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.581735e-11 | 10.339 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.051426e-11 | 10.297 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.907164e-11 | 10.229 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.653100e-11 | 10.116 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.127310e-11 | 10.090 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.619427e-11 | 10.065 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.147994e-10 | 9.940 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.248185e-10 | 9.904 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.293164e-10 | 9.888 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.459021e-10 | 9.836 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.011699e-10 | 9.696 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.291354e-10 | 9.640 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.861330e-10 | 9.543 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.472405e-10 | 9.459 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.474772e-10 | 9.459 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.776457e-10 | 9.423 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.385459e-10 | 9.358 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.612895e-10 | 9.251 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.472589e-10 | 9.262 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.094588e-10 | 9.215 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.094588e-10 | 9.215 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.299454e-10 | 9.137 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.511400e-10 | 9.124 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.626862e-10 | 9.017 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.082590e-09 | 8.966 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.200071e-09 | 8.921 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.227624e-09 | 8.911 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.414721e-09 | 8.849 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.584742e-09 | 8.800 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.678468e-09 | 8.775 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.003256e-09 | 8.698 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.109436e-09 | 8.676 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.357367e-09 | 8.628 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.388961e-09 | 8.622 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.751689e-09 | 8.560 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.718467e-09 | 8.566 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.063654e-09 | 8.514 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.063654e-09 | 8.514 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.145259e-09 | 8.502 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.269211e-09 | 8.486 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.583737e-09 | 8.339 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.583737e-09 | 8.339 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.613252e-09 | 8.336 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.599016e-09 | 8.252 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.708640e-09 | 8.243 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.156520e-09 | 8.211 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.162713e-09 | 8.210 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.377704e-09 | 8.195 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.116792e-09 | 8.148 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.660312e-09 | 8.116 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.355150e-09 | 8.133 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.660312e-09 | 8.116 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.317681e-09 | 8.080 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.588237e-09 | 8.066 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.721932e-09 | 8.059 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.185025e-09 | 8.037 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.452007e-09 | 8.024 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.106706e-08 | 7.956 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.106706e-08 | 7.956 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.113296e-08 | 7.953 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.343673e-08 | 7.872 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.421827e-08 | 7.847 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.816815e-08 | 7.741 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.825022e-08 | 7.739 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.948075e-08 | 7.710 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.606083e-08 | 7.584 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.661052e-08 | 7.575 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.857661e-08 | 7.544 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.156577e-08 | 7.501 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.493450e-08 | 7.457 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.902103e-08 | 7.409 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.381936e-08 | 7.358 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.992641e-08 | 7.302 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.992641e-08 | 7.302 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.785497e-08 | 7.109 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.971836e-08 | 7.098 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.714216e-08 | 7.060 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.343797e-08 | 7.079 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.113630e-08 | 7.040 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.753717e-08 | 7.011 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.334484e-07 | 6.875 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.673023e-07 | 6.776 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.688453e-07 | 6.773 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.834275e-07 | 6.737 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.073142e-07 | 6.683 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.465042e-07 | 6.608 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.524401e-07 | 6.598 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.578418e-07 | 6.589 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.625319e-07 | 6.581 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.631251e-07 | 6.580 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.767742e-07 | 6.558 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.304250e-07 | 6.481 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.604678e-07 | 6.443 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.604678e-07 | 6.443 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.660759e-07 | 6.436 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.197297e-07 | 6.377 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.232143e-07 | 6.281 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.164441e-07 | 6.210 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.809088e-07 | 6.167 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.951081e-07 | 6.158 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.066662e-07 | 6.093 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.184110e-07 | 6.087 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.543147e-07 | 6.068 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.762468e-07 | 6.010 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.129203e-06 | 5.947 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.199771e-06 | 5.921 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.251850e-06 | 5.902 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.310962e-06 | 5.882 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.339643e-06 | 5.873 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.476766e-06 | 5.831 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.550955e-06 | 5.809 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.562941e-06 | 5.806 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.690109e-06 | 5.772 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.690109e-06 | 5.772 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.733694e-06 | 5.761 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.874066e-06 | 5.727 | 0 | 0 |
| Translation | R-HSA-72766 | 2.029048e-06 | 5.693 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.093242e-06 | 5.679 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.093242e-06 | 5.679 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.294872e-06 | 5.639 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.569966e-06 | 5.590 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.649487e-06 | 5.577 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.649487e-06 | 5.577 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.992068e-06 | 5.524 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.118081e-06 | 5.506 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.519815e-06 | 5.453 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.865081e-06 | 5.413 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.967825e-06 | 5.401 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.981012e-06 | 5.400 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.078388e-06 | 5.390 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.799326e-06 | 5.319 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.943876e-06 | 5.306 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.601987e-06 | 5.252 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.944181e-06 | 5.226 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.229363e-06 | 5.206 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.001805e-06 | 5.155 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.291903e-06 | 5.081 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.291903e-06 | 5.081 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.400305e-06 | 5.076 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.088294e-05 | 4.963 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.047219e-05 | 4.980 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.138774e-05 | 4.944 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.179529e-05 | 4.928 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.386984e-05 | 4.858 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.449904e-05 | 4.839 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.456935e-05 | 4.837 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.584211e-05 | 4.800 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.648390e-05 | 4.783 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.678811e-05 | 4.775 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.750480e-05 | 4.757 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.840000e-05 | 4.735 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.132895e-05 | 4.671 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.166805e-05 | 4.664 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.434251e-05 | 4.614 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.454352e-05 | 4.610 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.486337e-05 | 4.604 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.594466e-05 | 4.586 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.361820e-05 | 4.473 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.016969e-05 | 4.520 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.081453e-05 | 4.511 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.252350e-05 | 4.488 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.440369e-05 | 4.463 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.580167e-05 | 4.446 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.975791e-05 | 4.401 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.117350e-05 | 4.385 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.667162e-05 | 4.331 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.734989e-05 | 4.325 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.191032e-05 | 4.285 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.589133e-05 | 4.253 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.727380e-05 | 4.242 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.249817e-05 | 4.204 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.808329e-05 | 4.167 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.808329e-05 | 4.167 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.773314e-05 | 4.109 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.876628e-05 | 4.104 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.027212e-05 | 4.095 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.264857e-05 | 4.083 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.453080e-05 | 4.073 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.588900e-05 | 4.066 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.848157e-05 | 4.053 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.151456e-04 | 3.939 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.026568e-04 | 3.989 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.152640e-04 | 3.938 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.135107e-04 | 3.945 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.182122e-04 | 3.927 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.255555e-04 | 3.901 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.258384e-04 | 3.900 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.258384e-04 | 3.900 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.309630e-04 | 3.883 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.477014e-04 | 3.831 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.499832e-04 | 3.824 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.499832e-04 | 3.824 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.522360e-04 | 3.817 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.601409e-04 | 3.795 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.620682e-04 | 3.790 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.622315e-04 | 3.790 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.628943e-04 | 3.788 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.635132e-04 | 3.786 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.911457e-04 | 3.719 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.911457e-04 | 3.719 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.911457e-04 | 3.719 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.911457e-04 | 3.719 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.052682e-04 | 3.688 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.127158e-04 | 3.672 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.157909e-04 | 3.666 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.323304e-04 | 3.634 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.323304e-04 | 3.634 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.474885e-04 | 3.606 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.564902e-04 | 3.591 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.582103e-04 | 3.588 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.625690e-04 | 3.581 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.975536e-04 | 3.526 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.003426e-04 | 3.522 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.117894e-04 | 3.506 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.558804e-04 | 3.449 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.138232e-04 | 3.503 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.771809e-04 | 3.423 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.928441e-04 | 3.406 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.930837e-04 | 3.406 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.947427e-04 | 3.404 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.287417e-04 | 3.368 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.423913e-04 | 3.354 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.423913e-04 | 3.354 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.438384e-04 | 3.353 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.998997e-04 | 3.301 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.998997e-04 | 3.301 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.027130e-04 | 3.299 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.150354e-04 | 3.288 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.150354e-04 | 3.288 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.914530e-04 | 3.228 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.132457e-04 | 3.212 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.447110e-04 | 3.191 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.447110e-04 | 3.191 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.618979e-04 | 3.179 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.720115e-04 | 3.173 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.989195e-04 | 3.156 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.989195e-04 | 3.156 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.215278e-04 | 3.142 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.382973e-04 | 3.077 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.433220e-04 | 3.074 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.561417e-04 | 3.067 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.754155e-04 | 3.058 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.754155e-04 | 3.058 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.754155e-04 | 3.058 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.754155e-04 | 3.058 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.754155e-04 | 3.058 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.572792e-04 | 3.019 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.012739e-03 | 2.995 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.048950e-03 | 2.979 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.048950e-03 | 2.979 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.100828e-03 | 2.958 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.267064e-03 | 2.897 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.575438e-03 | 2.803 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.575438e-03 | 2.803 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.459236e-03 | 2.836 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.575438e-03 | 2.803 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.429768e-03 | 2.845 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.374956e-03 | 2.862 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.331451e-03 | 2.876 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.376015e-03 | 2.861 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.391111e-03 | 2.857 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.576962e-03 | 2.802 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.576962e-03 | 2.802 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.613094e-03 | 2.792 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.616718e-03 | 2.791 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.616718e-03 | 2.791 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.624051e-03 | 2.789 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.631262e-03 | 2.787 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.882420e-03 | 2.725 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.938917e-03 | 2.712 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.093422e-03 | 2.679 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.094548e-03 | 2.679 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.119825e-03 | 2.674 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.153803e-03 | 2.667 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.162599e-03 | 2.665 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.162599e-03 | 2.665 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.265863e-03 | 2.645 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.349591e-03 | 2.629 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.411940e-03 | 2.618 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.411940e-03 | 2.618 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.411940e-03 | 2.618 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.510738e-03 | 2.600 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.583722e-03 | 2.588 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.643550e-03 | 2.578 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.655737e-03 | 2.576 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.691949e-03 | 2.570 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.800589e-03 | 2.553 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.169304e-03 | 2.499 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.180158e-03 | 2.498 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.181236e-03 | 2.497 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.224169e-03 | 2.492 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.379844e-03 | 2.471 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.457412e-03 | 2.461 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.457412e-03 | 2.461 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.482324e-03 | 2.458 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.557062e-03 | 2.449 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.557062e-03 | 2.449 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.662888e-03 | 2.436 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.662888e-03 | 2.436 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.662888e-03 | 2.436 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.673043e-03 | 2.435 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.686455e-03 | 2.433 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.751880e-03 | 2.426 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.751880e-03 | 2.426 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.751880e-03 | 2.426 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.751880e-03 | 2.426 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.876807e-03 | 2.412 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.807183e-03 | 2.318 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.807183e-03 | 2.318 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.930444e-03 | 2.307 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.198833e-03 | 2.377 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.992019e-03 | 2.399 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.807183e-03 | 2.318 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.034236e-03 | 2.394 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.744868e-03 | 2.324 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.025304e-03 | 2.299 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.025304e-03 | 2.299 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.164978e-03 | 2.287 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.164978e-03 | 2.287 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.250991e-03 | 2.280 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.385941e-03 | 2.269 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.385941e-03 | 2.269 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.385941e-03 | 2.269 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.808217e-03 | 2.236 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.838709e-03 | 2.234 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.838709e-03 | 2.234 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.935771e-03 | 2.227 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.076718e-03 | 2.216 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.144915e-03 | 2.211 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.342785e-03 | 2.198 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.367738e-03 | 2.196 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.367738e-03 | 2.196 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.508910e-03 | 2.186 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.508910e-03 | 2.186 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.508910e-03 | 2.186 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.672051e-03 | 2.176 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.672051e-03 | 2.176 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.074770e-03 | 2.150 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.239881e-03 | 2.140 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.521297e-03 | 2.124 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.605954e-03 | 2.119 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.605954e-03 | 2.119 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.825221e-03 | 2.107 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.027397e-03 | 2.095 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.095726e-03 | 2.092 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.123484e-03 | 2.090 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.267746e-03 | 2.083 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.267746e-03 | 2.083 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 9.595926e-03 | 2.018 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.610206e-03 | 2.065 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.115770e-02 | 1.952 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.914789e-03 | 2.004 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.005061e-02 | 1.998 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.115472e-03 | 2.040 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.115770e-02 | 1.952 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.136856e-02 | 1.944 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.054022e-02 | 1.977 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.809346e-03 | 2.008 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.809346e-03 | 2.008 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.809346e-03 | 2.008 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.136856e-02 | 1.944 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.115770e-02 | 1.952 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.948242e-03 | 2.048 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.054022e-02 | 1.977 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.786467e-03 | 2.009 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.092311e-02 | 1.962 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.044103e-02 | 1.981 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.136856e-02 | 1.944 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.943654e-03 | 2.002 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.595926e-03 | 2.018 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.595926e-03 | 2.018 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.159788e-02 | 1.936 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.183206e-02 | 1.927 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.187717e-02 | 1.925 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.255141e-02 | 1.901 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.269733e-02 | 1.896 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.280098e-02 | 1.893 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.289431e-02 | 1.890 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.289431e-02 | 1.890 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.297326e-02 | 1.887 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.297326e-02 | 1.887 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.334576e-02 | 1.875 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.341749e-02 | 1.872 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.391599e-02 | 1.856 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.419613e-02 | 1.848 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.419613e-02 | 1.848 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.419613e-02 | 1.848 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.419613e-02 | 1.848 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.420753e-02 | 1.847 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.421228e-02 | 1.847 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.456173e-02 | 1.837 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.501236e-02 | 1.824 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.517267e-02 | 1.819 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.517907e-02 | 1.819 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.534145e-02 | 1.814 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.547116e-02 | 1.810 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.578114e-02 | 1.802 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.593400e-02 | 1.798 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.601136e-02 | 1.796 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.714374e-02 | 1.766 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.726366e-02 | 1.763 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.726533e-02 | 1.763 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.749274e-02 | 1.757 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.776756e-02 | 1.750 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.776756e-02 | 1.750 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.784764e-02 | 1.748 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.794414e-02 | 1.746 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.808209e-02 | 1.743 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.808209e-02 | 1.743 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.808209e-02 | 1.743 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.808209e-02 | 1.743 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.808209e-02 | 1.743 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.808209e-02 | 1.743 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.829983e-02 | 1.738 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.854598e-02 | 1.732 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.864861e-02 | 1.729 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.976003e-02 | 1.704 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.991913e-02 | 1.701 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.991913e-02 | 1.701 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.992886e-02 | 1.701 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.025904e-02 | 1.693 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.110612e-02 | 1.676 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.145620e-02 | 1.668 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.191066e-02 | 1.659 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.191066e-02 | 1.659 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.191066e-02 | 1.659 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.191066e-02 | 1.659 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.191066e-02 | 1.659 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.208537e-02 | 1.656 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.208537e-02 | 1.656 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.219276e-02 | 1.654 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.229524e-02 | 1.652 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.230962e-02 | 1.652 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.291969e-02 | 1.640 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.332759e-02 | 1.632 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.332759e-02 | 1.632 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.358217e-02 | 1.627 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.370787e-02 | 1.625 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.412094e-02 | 1.618 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.412094e-02 | 1.618 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.460999e-02 | 1.609 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.460999e-02 | 1.609 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.460999e-02 | 1.609 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.460999e-02 | 1.609 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.460999e-02 | 1.609 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.460999e-02 | 1.609 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.483471e-02 | 1.605 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.516340e-02 | 1.599 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.571694e-02 | 1.590 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.630752e-02 | 1.580 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.641203e-02 | 1.578 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.671402e-02 | 1.573 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.671402e-02 | 1.573 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.671402e-02 | 1.573 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.671402e-02 | 1.573 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.711291e-02 | 1.567 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.711291e-02 | 1.567 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.740506e-02 | 1.562 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.756448e-02 | 1.560 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.760631e-02 | 1.559 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.807553e-02 | 1.419 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.558809e-02 | 1.449 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.859679e-02 | 1.413 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.859679e-02 | 1.413 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.204591e-02 | 1.494 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.332972e-02 | 1.477 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.332972e-02 | 1.477 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.332972e-02 | 1.477 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.810617e-02 | 1.419 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.810617e-02 | 1.419 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.405202e-02 | 1.468 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.755671e-02 | 1.425 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.053610e-02 | 1.515 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.456432e-02 | 1.461 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.347000e-02 | 1.475 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.192235e-02 | 1.496 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.964136e-02 | 1.402 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.140159e-02 | 1.383 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.320327e-02 | 1.479 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.104300e-02 | 1.508 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.104300e-02 | 1.508 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.481973e-02 | 1.458 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.204591e-02 | 1.494 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.043303e-02 | 1.517 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.892258e-02 | 1.410 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.807553e-02 | 1.419 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.481973e-02 | 1.458 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.302219e-02 | 1.366 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.977266e-02 | 1.526 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.391708e-02 | 1.470 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.859679e-02 | 1.413 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.192235e-02 | 1.496 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.552281e-02 | 1.449 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.811978e-02 | 1.419 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.640805e-02 | 1.439 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.192235e-02 | 1.496 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.391708e-02 | 1.470 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.769715e-02 | 1.424 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.558809e-02 | 1.449 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.300634e-02 | 1.481 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.755671e-02 | 1.425 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.302714e-02 | 1.481 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.330902e-02 | 1.363 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.332052e-02 | 1.363 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.449713e-02 | 1.352 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.482273e-02 | 1.349 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.626054e-02 | 1.335 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.668113e-02 | 1.331 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.668113e-02 | 1.331 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.787220e-02 | 1.320 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.787220e-02 | 1.320 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.787220e-02 | 1.320 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.803991e-02 | 1.318 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.803991e-02 | 1.318 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.837139e-02 | 1.315 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.889176e-02 | 1.311 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.889176e-02 | 1.311 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.898464e-02 | 1.310 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.898464e-02 | 1.310 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.937840e-02 | 1.306 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.937840e-02 | 1.306 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.937840e-02 | 1.306 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.937840e-02 | 1.306 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.119119e-02 | 1.291 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.133396e-02 | 1.290 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.146659e-02 | 1.288 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 5.224846e-02 | 1.282 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.224846e-02 | 1.282 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.224846e-02 | 1.282 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.338440e-02 | 1.273 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.373556e-02 | 1.270 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.380856e-02 | 1.269 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.445532e-02 | 1.264 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.445532e-02 | 1.264 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.445532e-02 | 1.264 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.462088e-02 | 1.263 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.489931e-02 | 1.260 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.510828e-02 | 1.259 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.569642e-02 | 1.254 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.639909e-02 | 1.249 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.807586e-02 | 1.236 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.807586e-02 | 1.236 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.022206e-02 | 1.220 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.037990e-02 | 1.219 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.037990e-02 | 1.219 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.037990e-02 | 1.219 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.037990e-02 | 1.219 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.037990e-02 | 1.219 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.037990e-02 | 1.219 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.041481e-02 | 1.219 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.041481e-02 | 1.219 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.041481e-02 | 1.219 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.148049e-02 | 1.211 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.148049e-02 | 1.211 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.169908e-02 | 1.210 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.169908e-02 | 1.210 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.169908e-02 | 1.210 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.206136e-02 | 1.207 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.338635e-02 | 1.198 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.338635e-02 | 1.198 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.338635e-02 | 1.198 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.338635e-02 | 1.198 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.338635e-02 | 1.198 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.338635e-02 | 1.198 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.338635e-02 | 1.198 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.512492e-02 | 1.186 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.516607e-02 | 1.186 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.537929e-02 | 1.185 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.537929e-02 | 1.185 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.537929e-02 | 1.185 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.564458e-02 | 1.183 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.564458e-02 | 1.183 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.564458e-02 | 1.183 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.564458e-02 | 1.183 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.600057e-02 | 1.180 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.634139e-02 | 1.178 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.677578e-02 | 1.175 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.677578e-02 | 1.175 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.701364e-02 | 1.174 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.701364e-02 | 1.174 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.701364e-02 | 1.174 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.876241e-02 | 1.163 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.876241e-02 | 1.163 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.876241e-02 | 1.163 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.883417e-02 | 1.162 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.883417e-02 | 1.162 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.883417e-02 | 1.162 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.883417e-02 | 1.162 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.883417e-02 | 1.162 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.891284e-02 | 1.162 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.908015e-02 | 1.161 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.908015e-02 | 1.161 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.922090e-02 | 1.160 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.922090e-02 | 1.160 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.922090e-02 | 1.160 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.922090e-02 | 1.160 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.981629e-02 | 1.156 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.981629e-02 | 1.156 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.984344e-02 | 1.156 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.015447e-02 | 1.154 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.037182e-02 | 1.153 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.354219e-02 | 1.133 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.630142e-02 | 1.117 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.630142e-02 | 1.117 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.630142e-02 | 1.117 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.651806e-02 | 1.116 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.901775e-02 | 1.102 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.071637e-02 | 1.093 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.119986e-02 | 1.090 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.255608e-02 | 1.083 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.255608e-02 | 1.083 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.255608e-02 | 1.083 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.255608e-02 | 1.083 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.255608e-02 | 1.083 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.255608e-02 | 1.083 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.271303e-02 | 1.082 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 8.343542e-02 | 1.079 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.343542e-02 | 1.079 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.343542e-02 | 1.079 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.364754e-02 | 1.078 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.431695e-02 | 1.074 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.431695e-02 | 1.074 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.431695e-02 | 1.074 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.653069e-02 | 1.063 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.695800e-02 | 1.061 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.695800e-02 | 1.061 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.729172e-02 | 1.059 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.729172e-02 | 1.059 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.729172e-02 | 1.059 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.829903e-02 | 1.054 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.829903e-02 | 1.054 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.830042e-02 | 1.054 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.830042e-02 | 1.054 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.830042e-02 | 1.054 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.830042e-02 | 1.054 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.902048e-02 | 1.051 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.902048e-02 | 1.051 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.902048e-02 | 1.051 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.082071e-02 | 1.042 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.082071e-02 | 1.042 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.280014e-02 | 1.032 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.280014e-02 | 1.032 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.280014e-02 | 1.032 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 9.280014e-02 | 1.032 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.297132e-02 | 1.032 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.523376e-02 | 1.021 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.628926e-02 | 1.016 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.628926e-02 | 1.016 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 9.672058e-02 | 1.014 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 9.672058e-02 | 1.014 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 9.672058e-02 | 1.014 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 9.672058e-02 | 1.014 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 9.672058e-02 | 1.014 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.672058e-02 | 1.014 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.672058e-02 | 1.014 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 9.672058e-02 | 1.014 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 9.672058e-02 | 1.014 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 9.672058e-02 | 1.014 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 9.672058e-02 | 1.014 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.672058e-02 | 1.014 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.750979e-02 | 1.011 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.750979e-02 | 1.011 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 9.750979e-02 | 1.011 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.750979e-02 | 1.011 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.832975e-02 | 1.007 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.878925e-02 | 1.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.969682e-02 | 1.001 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.996083e-02 | 1.000 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.996083e-02 | 1.000 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.004197e-01 | 0.998 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.009670e-01 | 0.996 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 1.009670e-01 | 0.996 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.840914e-01 | 0.735 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.840914e-01 | 0.735 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.840914e-01 | 0.735 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.840914e-01 | 0.735 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.840914e-01 | 0.735 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.840914e-01 | 0.735 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.252874e-01 | 0.902 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.252874e-01 | 0.902 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.252874e-01 | 0.902 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.599794e-01 | 0.796 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.599794e-01 | 0.796 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.599794e-01 | 0.796 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.033621e-01 | 0.986 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.033621e-01 | 0.986 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.033621e-01 | 0.986 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.033621e-01 | 0.986 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.033621e-01 | 0.986 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.249560e-01 | 0.903 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.249560e-01 | 0.903 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.249560e-01 | 0.903 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.961462e-01 | 0.707 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.961462e-01 | 0.707 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.961462e-01 | 0.707 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.961462e-01 | 0.707 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.961462e-01 | 0.707 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.480041e-01 | 0.830 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.480041e-01 | 0.830 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.136270e-01 | 0.945 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.722905e-01 | 0.764 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.722905e-01 | 0.764 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.722905e-01 | 0.764 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.308286e-01 | 0.883 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.308286e-01 | 0.883 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.308286e-01 | 0.883 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.144859e-01 | 0.941 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.490272e-01 | 0.827 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.490272e-01 | 0.827 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.976015e-01 | 0.704 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.288184e-01 | 0.890 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.439203e-01 | 0.842 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.439203e-01 | 0.842 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.238418e-01 | 0.907 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.238418e-01 | 0.907 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.880356e-01 | 0.726 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.880356e-01 | 0.726 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.502330e-01 | 0.823 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.893256e-01 | 0.723 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.893256e-01 | 0.723 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.375485e-01 | 0.862 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.682089e-01 | 0.774 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.742534e-01 | 0.759 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.880356e-01 | 0.726 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.787313e-01 | 0.748 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.134806e-01 | 0.945 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.144859e-01 | 0.941 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.070202e-01 | 0.971 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.597422e-01 | 0.797 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.742534e-01 | 0.759 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.599794e-01 | 0.796 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.033621e-01 | 0.986 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.480041e-01 | 0.830 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.939950e-01 | 0.712 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.422095e-01 | 0.847 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.215724e-01 | 0.915 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.252874e-01 | 0.902 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.252874e-01 | 0.902 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.145585e-01 | 0.941 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.856155e-01 | 0.731 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.400417e-01 | 0.854 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.722905e-01 | 0.764 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.597422e-01 | 0.797 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.649769e-01 | 0.783 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.115748e-01 | 0.952 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.502330e-01 | 0.823 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.933302e-01 | 0.714 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.139991e-01 | 0.943 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.139991e-01 | 0.943 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.599794e-01 | 0.796 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.599794e-01 | 0.796 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.033621e-01 | 0.986 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.249560e-01 | 0.903 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.070202e-01 | 0.971 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.769655e-01 | 0.752 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.020375e-01 | 0.695 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.242178e-01 | 0.906 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.933302e-01 | 0.714 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.076948e-01 | 0.968 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.144859e-01 | 0.941 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.068198e-01 | 0.971 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.308286e-01 | 0.883 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.917603e-01 | 0.717 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.145585e-01 | 0.941 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.072946e-01 | 0.969 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.840914e-01 | 0.735 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.599794e-01 | 0.796 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.961462e-01 | 0.707 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.722905e-01 | 0.764 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.976015e-01 | 0.704 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.880356e-01 | 0.726 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.367372e-01 | 0.864 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.502330e-01 | 0.823 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.120602e-01 | 0.951 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.336317e-01 | 0.874 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.076948e-01 | 0.968 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.722905e-01 | 0.764 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.115748e-01 | 0.952 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.230563e-01 | 0.910 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.490272e-01 | 0.827 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.726914e-01 | 0.763 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.006402e-01 | 0.698 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.017698e-01 | 0.992 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.201189e-01 | 0.920 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.230563e-01 | 0.910 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.139991e-01 | 0.943 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.640470e-01 | 0.785 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.480041e-01 | 0.830 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.872087e-01 | 0.728 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.938159e-01 | 0.713 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.961462e-01 | 0.707 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.490272e-01 | 0.827 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.111977e-01 | 0.954 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.288184e-01 | 0.890 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.489787e-01 | 0.827 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.961462e-01 | 0.707 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.230563e-01 | 0.910 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.975284e-01 | 0.704 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.762310e-01 | 0.754 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.525372e-01 | 0.817 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.183661e-01 | 0.927 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.855895e-01 | 0.731 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.129725e-01 | 0.947 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.880356e-01 | 0.726 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.210834e-01 | 0.917 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.599794e-01 | 0.796 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.961462e-01 | 0.707 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.923051e-01 | 0.716 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.490272e-01 | 0.827 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.880356e-01 | 0.726 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 1.597422e-01 | 0.797 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.062763e-01 | 0.686 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.086469e-01 | 0.681 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.086469e-01 | 0.681 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.086469e-01 | 0.681 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.086469e-01 | 0.681 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.086469e-01 | 0.681 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 2.086469e-01 | 0.681 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.095526e-01 | 0.679 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.095526e-01 | 0.679 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.095526e-01 | 0.679 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.095526e-01 | 0.679 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.109809e-01 | 0.676 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.109809e-01 | 0.676 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.120173e-01 | 0.674 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.150805e-01 | 0.667 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.206168e-01 | 0.656 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.206168e-01 | 0.656 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 2.212045e-01 | 0.655 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.237298e-01 | 0.650 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.237298e-01 | 0.650 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.237298e-01 | 0.650 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.237298e-01 | 0.650 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.237298e-01 | 0.650 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.237298e-01 | 0.650 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.237298e-01 | 0.650 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.237298e-01 | 0.650 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.271431e-01 | 0.644 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.291227e-01 | 0.640 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.291227e-01 | 0.640 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.291227e-01 | 0.640 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.295549e-01 | 0.639 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.298615e-01 | 0.639 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.298615e-01 | 0.639 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.331785e-01 | 0.632 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 2.331785e-01 | 0.632 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.331785e-01 | 0.632 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.331785e-01 | 0.632 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.418855e-01 | 0.616 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.418855e-01 | 0.616 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.476940e-01 | 0.606 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.476940e-01 | 0.606 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.502193e-01 | 0.602 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.515783e-01 | 0.599 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.515783e-01 | 0.599 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.515783e-01 | 0.599 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.515783e-01 | 0.599 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.585775e-01 | 0.587 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.628128e-01 | 0.580 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.630159e-01 | 0.580 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.630159e-01 | 0.580 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.630159e-01 | 0.580 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.630159e-01 | 0.580 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.630159e-01 | 0.580 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.630159e-01 | 0.580 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.630159e-01 | 0.580 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.630159e-01 | 0.580 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.630159e-01 | 0.580 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.630159e-01 | 0.580 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.630159e-01 | 0.580 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.630159e-01 | 0.580 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.641817e-01 | 0.578 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.655545e-01 | 0.576 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.655545e-01 | 0.576 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.655545e-01 | 0.576 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.666331e-01 | 0.574 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.701134e-01 | 0.568 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.701134e-01 | 0.568 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.705709e-01 | 0.568 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 2.705709e-01 | 0.568 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.705709e-01 | 0.568 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.705709e-01 | 0.568 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.705709e-01 | 0.568 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.705709e-01 | 0.568 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.705709e-01 | 0.568 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.705709e-01 | 0.568 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.736984e-01 | 0.563 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.736984e-01 | 0.563 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.736984e-01 | 0.563 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.736984e-01 | 0.563 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.736984e-01 | 0.563 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.755631e-01 | 0.560 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.776584e-01 | 0.556 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.776584e-01 | 0.556 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.776584e-01 | 0.556 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.810695e-01 | 0.551 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.810725e-01 | 0.551 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.844687e-01 | 0.546 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.844687e-01 | 0.546 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.858783e-01 | 0.544 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.858783e-01 | 0.544 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.864830e-01 | 0.543 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.864830e-01 | 0.543 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.879220e-01 | 0.541 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.961251e-01 | 0.529 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.961251e-01 | 0.529 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.967996e-01 | 0.528 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.967996e-01 | 0.528 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.997144e-01 | 0.523 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.050992e-01 | 0.516 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.050992e-01 | 0.516 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.050992e-01 | 0.516 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.050992e-01 | 0.516 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.050992e-01 | 0.516 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.050992e-01 | 0.516 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.053688e-01 | 0.515 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.053688e-01 | 0.515 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.079077e-01 | 0.512 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.079077e-01 | 0.512 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.079077e-01 | 0.512 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.127132e-01 | 0.505 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.127132e-01 | 0.505 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.187658e-01 | 0.497 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.205727e-01 | 0.494 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.262747e-01 | 0.486 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.278560e-01 | 0.484 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.318666e-01 | 0.479 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.326404e-01 | 0.478 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.326404e-01 | 0.478 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 3.343100e-01 | 0.476 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.343100e-01 | 0.476 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.343100e-01 | 0.476 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.343100e-01 | 0.476 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.343100e-01 | 0.476 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.343100e-01 | 0.476 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.343100e-01 | 0.476 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.343100e-01 | 0.476 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.343100e-01 | 0.476 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.343100e-01 | 0.476 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.343100e-01 | 0.476 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.343100e-01 | 0.476 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.343100e-01 | 0.476 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.370041e-01 | 0.472 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.399508e-01 | 0.469 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.415317e-01 | 0.467 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.448499e-01 | 0.462 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.448499e-01 | 0.462 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.448499e-01 | 0.462 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.448499e-01 | 0.462 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.448499e-01 | 0.462 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.448499e-01 | 0.462 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.448499e-01 | 0.462 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.448499e-01 | 0.462 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.448499e-01 | 0.462 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.448499e-01 | 0.462 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.448499e-01 | 0.462 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.448499e-01 | 0.462 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.448499e-01 | 0.462 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.448499e-01 | 0.462 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.449641e-01 | 0.462 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.449641e-01 | 0.462 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.495405e-01 | 0.457 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.556993e-01 | 0.449 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.581637e-01 | 0.446 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.601372e-01 | 0.444 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.601372e-01 | 0.444 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.601372e-01 | 0.444 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.601372e-01 | 0.444 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.634127e-01 | 0.440 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.643389e-01 | 0.438 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.647253e-01 | 0.438 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.647253e-01 | 0.438 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.737233e-01 | 0.427 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.737233e-01 | 0.427 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.793313e-01 | 0.421 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.795469e-01 | 0.421 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.811247e-01 | 0.419 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.811247e-01 | 0.419 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.811247e-01 | 0.419 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.811247e-01 | 0.419 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.811247e-01 | 0.419 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.811247e-01 | 0.419 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.811247e-01 | 0.419 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.811247e-01 | 0.419 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.811247e-01 | 0.419 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.846197e-01 | 0.415 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.846197e-01 | 0.415 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.846197e-01 | 0.415 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.871086e-01 | 0.412 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.874588e-01 | 0.412 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.874588e-01 | 0.412 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.874588e-01 | 0.412 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.874588e-01 | 0.412 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 3.874588e-01 | 0.412 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.987112e-01 | 0.399 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.987112e-01 | 0.399 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.987112e-01 | 0.399 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.987112e-01 | 0.399 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.987112e-01 | 0.399 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.987112e-01 | 0.399 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.987112e-01 | 0.399 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.987112e-01 | 0.399 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.987112e-01 | 0.399 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.991507e-01 | 0.399 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.010381e-01 | 0.397 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.040771e-01 | 0.394 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.044812e-01 | 0.393 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.044812e-01 | 0.393 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.097677e-01 | 0.387 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.097677e-01 | 0.387 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.103011e-01 | 0.387 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.144889e-01 | 0.382 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.144889e-01 | 0.382 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.165157e-01 | 0.380 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.165157e-01 | 0.380 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.165157e-01 | 0.380 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.165157e-01 | 0.380 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.165157e-01 | 0.380 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.242615e-01 | 0.372 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.242615e-01 | 0.372 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.270594e-01 | 0.370 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.322483e-01 | 0.364 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.322483e-01 | 0.364 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.322483e-01 | 0.364 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.322483e-01 | 0.364 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.322483e-01 | 0.364 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.347721e-01 | 0.362 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.409050e-01 | 0.356 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.411248e-01 | 0.355 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.411248e-01 | 0.355 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.411248e-01 | 0.355 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.411248e-01 | 0.355 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.411942e-01 | 0.355 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.439151e-01 | 0.353 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.464465e-01 | 0.350 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.476769e-01 | 0.349 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.508545e-01 | 0.346 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.508545e-01 | 0.346 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.508545e-01 | 0.346 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.508545e-01 | 0.346 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.508545e-01 | 0.346 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.508545e-01 | 0.346 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.524527e-01 | 0.344 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.544884e-01 | 0.342 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.555405e-01 | 0.341 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.568853e-01 | 0.340 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.568853e-01 | 0.340 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.568853e-01 | 0.340 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.568853e-01 | 0.340 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.568853e-01 | 0.340 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.568853e-01 | 0.340 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.568853e-01 | 0.340 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.568853e-01 | 0.340 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.568853e-01 | 0.340 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.568853e-01 | 0.340 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.568853e-01 | 0.340 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.568853e-01 | 0.340 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.568853e-01 | 0.340 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.568853e-01 | 0.340 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.568853e-01 | 0.340 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.613475e-01 | 0.336 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.628209e-01 | 0.335 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.672771e-01 | 0.330 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 4.672771e-01 | 0.330 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.700041e-01 | 0.328 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.752247e-01 | 0.323 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.764317e-01 | 0.322 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 4.764317e-01 | 0.322 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.764317e-01 | 0.322 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.826751e-01 | 0.316 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.840134e-01 | 0.315 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.840134e-01 | 0.315 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.840134e-01 | 0.315 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.840134e-01 | 0.315 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 4.840134e-01 | 0.315 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.840134e-01 | 0.315 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.840134e-01 | 0.315 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.840134e-01 | 0.315 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 4.840134e-01 | 0.315 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.840134e-01 | 0.315 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.840134e-01 | 0.315 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.840134e-01 | 0.315 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.840134e-01 | 0.315 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.863941e-01 | 0.313 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.928689e-01 | 0.307 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.928689e-01 | 0.307 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.928689e-01 | 0.307 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.928689e-01 | 0.307 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.971276e-01 | 0.304 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.980275e-01 | 0.303 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.980275e-01 | 0.303 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.017057e-01 | 0.300 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.017057e-01 | 0.300 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.017057e-01 | 0.300 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.017057e-01 | 0.300 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.046028e-01 | 0.297 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.070203e-01 | 0.295 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.094343e-01 | 0.293 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.094343e-01 | 0.293 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.094343e-01 | 0.293 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.094343e-01 | 0.293 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.094343e-01 | 0.293 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.094343e-01 | 0.293 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.094343e-01 | 0.293 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.094343e-01 | 0.293 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.158995e-01 | 0.287 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.158995e-01 | 0.287 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.158995e-01 | 0.287 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.158995e-01 | 0.287 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.158995e-01 | 0.287 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.158995e-01 | 0.287 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.158995e-01 | 0.287 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 5.178350e-01 | 0.286 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.204580e-01 | 0.284 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.204580e-01 | 0.284 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.204580e-01 | 0.284 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.265553e-01 | 0.279 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.400011e-01 | 0.268 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.400011e-01 | 0.268 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.400011e-01 | 0.268 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.400011e-01 | 0.268 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.413544e-01 | 0.267 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.421214e-01 | 0.266 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 5.421214e-01 | 0.266 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.464486e-01 | 0.262 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.464486e-01 | 0.262 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.464486e-01 | 0.262 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.509517e-01 | 0.259 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.517045e-01 | 0.258 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.569017e-01 | 0.254 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.569017e-01 | 0.254 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.569017e-01 | 0.254 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.569017e-01 | 0.254 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.569017e-01 | 0.254 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.569017e-01 | 0.254 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.569017e-01 | 0.254 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.569017e-01 | 0.254 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.569017e-01 | 0.254 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.569017e-01 | 0.254 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.569017e-01 | 0.254 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.569017e-01 | 0.254 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.569017e-01 | 0.254 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.569017e-01 | 0.254 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.569017e-01 | 0.254 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.569017e-01 | 0.254 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.569017e-01 | 0.254 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.569017e-01 | 0.254 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.569017e-01 | 0.254 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.569017e-01 | 0.254 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.569017e-01 | 0.254 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.569017e-01 | 0.254 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.569017e-01 | 0.254 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.570096e-01 | 0.254 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.570096e-01 | 0.254 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.603044e-01 | 0.252 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.656838e-01 | 0.247 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.656838e-01 | 0.247 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.656838e-01 | 0.247 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.656838e-01 | 0.247 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.704209e-01 | 0.244 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 5.756210e-01 | 0.240 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 5.756210e-01 | 0.240 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.756210e-01 | 0.240 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.801107e-01 | 0.236 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.884875e-01 | 0.230 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.884875e-01 | 0.230 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.921243e-01 | 0.228 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.993950e-01 | 0.222 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.993950e-01 | 0.222 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.997787e-01 | 0.222 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.997787e-01 | 0.222 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.997787e-01 | 0.222 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.997787e-01 | 0.222 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.997787e-01 | 0.222 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.997787e-01 | 0.222 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.997787e-01 | 0.222 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.997787e-01 | 0.222 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.997787e-01 | 0.222 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.997787e-01 | 0.222 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.997787e-01 | 0.222 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.997787e-01 | 0.222 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.033971e-01 | 0.219 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.033971e-01 | 0.219 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.033971e-01 | 0.219 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.033971e-01 | 0.219 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.033971e-01 | 0.219 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.033971e-01 | 0.219 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.067254e-01 | 0.217 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.105061e-01 | 0.214 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.105061e-01 | 0.214 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.105061e-01 | 0.214 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.256424e-01 | 0.204 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.256424e-01 | 0.204 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.263247e-01 | 0.203 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.283330e-01 | 0.202 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.297738e-01 | 0.201 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.297738e-01 | 0.201 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.317207e-01 | 0.199 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.317207e-01 | 0.199 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.363187e-01 | 0.196 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.363187e-01 | 0.196 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.363187e-01 | 0.196 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.363187e-01 | 0.196 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.385089e-01 | 0.195 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.385089e-01 | 0.195 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.385089e-01 | 0.195 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.385089e-01 | 0.195 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.385089e-01 | 0.195 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.385089e-01 | 0.195 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.385089e-01 | 0.195 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.385089e-01 | 0.195 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.385089e-01 | 0.195 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.385089e-01 | 0.195 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.385089e-01 | 0.195 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.385089e-01 | 0.195 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.385089e-01 | 0.195 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.385089e-01 | 0.195 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.385089e-01 | 0.195 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.385089e-01 | 0.195 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.385089e-01 | 0.195 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.417645e-01 | 0.193 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.521194e-01 | 0.186 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.521194e-01 | 0.186 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.521194e-01 | 0.186 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.547620e-01 | 0.184 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.547620e-01 | 0.184 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.556409e-01 | 0.183 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.709580e-01 | 0.173 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.709580e-01 | 0.173 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.716962e-01 | 0.173 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.716962e-01 | 0.173 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.716962e-01 | 0.173 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.716962e-01 | 0.173 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.716962e-01 | 0.173 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.716962e-01 | 0.173 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.716962e-01 | 0.173 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.726801e-01 | 0.172 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.734931e-01 | 0.172 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.734931e-01 | 0.172 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.734931e-01 | 0.172 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.734931e-01 | 0.172 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.734931e-01 | 0.172 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.734931e-01 | 0.172 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.734931e-01 | 0.172 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.734931e-01 | 0.172 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.734931e-01 | 0.172 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.734931e-01 | 0.172 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.734931e-01 | 0.172 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.734931e-01 | 0.172 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.734931e-01 | 0.172 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.734931e-01 | 0.172 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.734931e-01 | 0.172 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.734931e-01 | 0.172 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.748680e-01 | 0.171 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.755856e-01 | 0.170 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.783832e-01 | 0.169 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.783832e-01 | 0.169 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.783832e-01 | 0.169 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.783832e-01 | 0.169 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.783832e-01 | 0.169 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.783832e-01 | 0.169 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.783832e-01 | 0.169 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.783832e-01 | 0.169 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.874000e-01 | 0.163 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.874000e-01 | 0.163 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.874586e-01 | 0.163 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.904508e-01 | 0.161 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.904508e-01 | 0.161 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.006681e-01 | 0.154 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.006681e-01 | 0.154 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.006681e-01 | 0.154 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.006681e-01 | 0.154 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.006681e-01 | 0.154 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.017775e-01 | 0.154 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.022233e-01 | 0.154 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.022233e-01 | 0.154 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.022233e-01 | 0.154 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.032521e-01 | 0.153 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.032521e-01 | 0.153 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.032521e-01 | 0.153 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.032521e-01 | 0.153 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.032521e-01 | 0.153 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.032521e-01 | 0.153 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.032521e-01 | 0.153 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.050936e-01 | 0.152 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.050936e-01 | 0.152 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.050936e-01 | 0.152 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.050936e-01 | 0.152 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.050936e-01 | 0.152 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.050936e-01 | 0.152 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.050936e-01 | 0.152 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.050936e-01 | 0.152 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.050936e-01 | 0.152 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.050936e-01 | 0.152 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.050936e-01 | 0.152 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.050936e-01 | 0.152 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.050936e-01 | 0.152 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.050936e-01 | 0.152 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.050936e-01 | 0.152 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.050936e-01 | 0.152 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.059858e-01 | 0.151 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.083874e-01 | 0.150 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.083874e-01 | 0.150 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 7.109799e-01 | 0.148 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.121916e-01 | 0.147 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.185143e-01 | 0.144 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.216539e-01 | 0.142 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.216539e-01 | 0.142 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.216539e-01 | 0.142 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.216539e-01 | 0.142 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.216539e-01 | 0.142 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.242375e-01 | 0.140 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.242375e-01 | 0.140 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.242375e-01 | 0.140 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.255142e-01 | 0.139 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.331888e-01 | 0.135 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.331888e-01 | 0.135 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.331888e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.331888e-01 | 0.135 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.336373e-01 | 0.135 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.336373e-01 | 0.135 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.336373e-01 | 0.135 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.336373e-01 | 0.135 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.336373e-01 | 0.135 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.336373e-01 | 0.135 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.336373e-01 | 0.135 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.336373e-01 | 0.135 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.355683e-01 | 0.133 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.383557e-01 | 0.132 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.393331e-01 | 0.131 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.413833e-01 | 0.130 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.418433e-01 | 0.130 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.419600e-01 | 0.130 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.509396e-01 | 0.124 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.573895e-01 | 0.121 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.573895e-01 | 0.121 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.594198e-01 | 0.120 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.594198e-01 | 0.120 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.594198e-01 | 0.120 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.594198e-01 | 0.120 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.594198e-01 | 0.120 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.594198e-01 | 0.120 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.594198e-01 | 0.120 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.594198e-01 | 0.120 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.594198e-01 | 0.120 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.597853e-01 | 0.119 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.599029e-01 | 0.119 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.607948e-01 | 0.119 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.639822e-01 | 0.117 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.664472e-01 | 0.116 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.721703e-01 | 0.112 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.772620e-01 | 0.109 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.772620e-01 | 0.109 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.772620e-01 | 0.109 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.772620e-01 | 0.109 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.827081e-01 | 0.106 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.827081e-01 | 0.106 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.827081e-01 | 0.106 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.827081e-01 | 0.106 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.827081e-01 | 0.106 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.827081e-01 | 0.106 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.827081e-01 | 0.106 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.834878e-01 | 0.106 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.861291e-01 | 0.105 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.861291e-01 | 0.105 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.862052e-01 | 0.104 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.862052e-01 | 0.104 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.862052e-01 | 0.104 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.891291e-01 | 0.103 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.935117e-01 | 0.100 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.935117e-01 | 0.100 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.979696e-01 | 0.098 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.979696e-01 | 0.098 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.995157e-01 | 0.097 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.995157e-01 | 0.097 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.033278e-01 | 0.095 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.037433e-01 | 0.095 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.037433e-01 | 0.095 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.037433e-01 | 0.095 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.037433e-01 | 0.095 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.037433e-01 | 0.095 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.037433e-01 | 0.095 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.037433e-01 | 0.095 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.037433e-01 | 0.095 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.042992e-01 | 0.095 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.087040e-01 | 0.092 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.087040e-01 | 0.092 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.087040e-01 | 0.092 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.087040e-01 | 0.092 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.087040e-01 | 0.092 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.092748e-01 | 0.092 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.100562e-01 | 0.091 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.121243e-01 | 0.090 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.125735e-01 | 0.090 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.133200e-01 | 0.090 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.198814e-01 | 0.086 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.198814e-01 | 0.086 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.209826e-01 | 0.086 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.227433e-01 | 0.085 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.227433e-01 | 0.085 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.227433e-01 | 0.085 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.227433e-01 | 0.085 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.227433e-01 | 0.085 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.227433e-01 | 0.085 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.227433e-01 | 0.085 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.227433e-01 | 0.085 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.227433e-01 | 0.085 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.227433e-01 | 0.085 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.227433e-01 | 0.085 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.228914e-01 | 0.085 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.228914e-01 | 0.085 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.228914e-01 | 0.085 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.228914e-01 | 0.085 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.228914e-01 | 0.085 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.240547e-01 | 0.084 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.283429e-01 | 0.082 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.283429e-01 | 0.082 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.353315e-01 | 0.078 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.353315e-01 | 0.078 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.353315e-01 | 0.078 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.361259e-01 | 0.078 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.361259e-01 | 0.078 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.361259e-01 | 0.078 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.361259e-01 | 0.078 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.383006e-01 | 0.077 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.399049e-01 | 0.076 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.399049e-01 | 0.076 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.399049e-01 | 0.076 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.399049e-01 | 0.076 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.399049e-01 | 0.076 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.399049e-01 | 0.076 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.399049e-01 | 0.076 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.399049e-01 | 0.076 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.399049e-01 | 0.076 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.399049e-01 | 0.076 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.438974e-01 | 0.074 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.461300e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.467310e-01 | 0.072 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.469983e-01 | 0.072 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.484590e-01 | 0.071 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.484590e-01 | 0.071 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.484590e-01 | 0.071 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.484590e-01 | 0.071 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.551449e-01 | 0.068 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.554059e-01 | 0.068 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.554059e-01 | 0.068 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.554059e-01 | 0.068 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.554059e-01 | 0.068 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.560243e-01 | 0.068 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.560243e-01 | 0.068 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.599412e-01 | 0.066 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.599412e-01 | 0.066 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.599412e-01 | 0.066 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.617581e-01 | 0.065 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.688025e-01 | 0.061 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.694068e-01 | 0.061 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.694068e-01 | 0.061 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.694068e-01 | 0.061 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.694068e-01 | 0.061 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.694068e-01 | 0.061 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.694068e-01 | 0.061 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.694068e-01 | 0.061 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.694068e-01 | 0.061 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.698039e-01 | 0.061 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.698039e-01 | 0.061 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.706216e-01 | 0.060 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.743878e-01 | 0.058 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.744048e-01 | 0.058 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.805478e-01 | 0.055 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.805478e-01 | 0.055 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.812581e-01 | 0.055 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.820527e-01 | 0.055 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.820527e-01 | 0.055 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.820527e-01 | 0.055 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.820527e-01 | 0.055 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.820527e-01 | 0.055 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.820527e-01 | 0.055 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.820527e-01 | 0.055 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.820527e-01 | 0.055 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.827910e-01 | 0.054 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.827910e-01 | 0.054 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.827910e-01 | 0.054 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.868112e-01 | 0.052 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.874431e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.897655e-01 | 0.051 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.897655e-01 | 0.051 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.897655e-01 | 0.051 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.897655e-01 | 0.051 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.925619e-01 | 0.049 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.925619e-01 | 0.049 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.934748e-01 | 0.049 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.934748e-01 | 0.049 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.934748e-01 | 0.049 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.024902e-01 | 0.045 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.029614e-01 | 0.044 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.062504e-01 | 0.043 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.062504e-01 | 0.043 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.085293e-01 | 0.042 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.115469e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.131094e-01 | 0.039 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 9.131094e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.131094e-01 | 0.039 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.131094e-01 | 0.039 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.131094e-01 | 0.039 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.135999e-01 | 0.039 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.135999e-01 | 0.039 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.138156e-01 | 0.039 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.142546e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.188313e-01 | 0.037 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.204058e-01 | 0.036 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.215254e-01 | 0.035 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.215254e-01 | 0.035 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.215254e-01 | 0.035 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.215254e-01 | 0.035 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.215254e-01 | 0.035 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.215254e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.215254e-01 | 0.035 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.215254e-01 | 0.035 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.233774e-01 | 0.035 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.247354e-01 | 0.034 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.255910e-01 | 0.034 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.267044e-01 | 0.033 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.291267e-01 | 0.032 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.291267e-01 | 0.032 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.291267e-01 | 0.032 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.291267e-01 | 0.032 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.291267e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.291267e-01 | 0.032 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.325302e-01 | 0.030 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.325302e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.359922e-01 | 0.029 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.359922e-01 | 0.029 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.359922e-01 | 0.029 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.359922e-01 | 0.029 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.359922e-01 | 0.029 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.384244e-01 | 0.028 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.398487e-01 | 0.027 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.421929e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.421929e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.421929e-01 | 0.026 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.421929e-01 | 0.026 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.421929e-01 | 0.026 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.477933e-01 | 0.023 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.477933e-01 | 0.023 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.477933e-01 | 0.023 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.477933e-01 | 0.023 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.477933e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.477933e-01 | 0.023 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.477933e-01 | 0.023 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.477933e-01 | 0.023 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.483963e-01 | 0.023 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.517264e-01 | 0.021 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.528514e-01 | 0.021 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.556387e-01 | 0.020 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.560526e-01 | 0.020 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.574197e-01 | 0.019 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.574197e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.574197e-01 | 0.019 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.574197e-01 | 0.019 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.574197e-01 | 0.019 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.574197e-01 | 0.019 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.592464e-01 | 0.018 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.602640e-01 | 0.018 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.615457e-01 | 0.017 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.640830e-01 | 0.016 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.640830e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.652720e-01 | 0.015 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.652720e-01 | 0.015 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.652720e-01 | 0.015 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.662077e-01 | 0.015 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.662077e-01 | 0.015 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.684573e-01 | 0.014 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.686375e-01 | 0.014 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.686988e-01 | 0.014 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.710551e-01 | 0.013 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.716770e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.716770e-01 | 0.012 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.716770e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.723873e-01 | 0.012 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.723873e-01 | 0.012 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.731691e-01 | 0.012 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.732812e-01 | 0.012 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.743295e-01 | 0.011 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.744221e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.744221e-01 | 0.011 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.744221e-01 | 0.011 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.744221e-01 | 0.011 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.751704e-01 | 0.011 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.769013e-01 | 0.010 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.788783e-01 | 0.009 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.791403e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.802618e-01 | 0.009 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.811624e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.811624e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.812366e-01 | 0.008 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.812366e-01 | 0.008 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.812366e-01 | 0.008 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.813783e-01 | 0.008 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.818431e-01 | 0.008 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.828068e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.829886e-01 | 0.007 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.829886e-01 | 0.007 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.829886e-01 | 0.007 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.832214e-01 | 0.007 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.833153e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.835839e-01 | 0.007 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.837584e-01 | 0.007 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.838539e-01 | 0.007 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.846378e-01 | 0.007 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.846378e-01 | 0.007 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.846378e-01 | 0.007 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.855733e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.861272e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.861272e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.861272e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.861272e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.874724e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.879047e-01 | 0.005 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.884647e-01 | 0.005 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.886871e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.886871e-01 | 0.005 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.886871e-01 | 0.005 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.886871e-01 | 0.005 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.887375e-01 | 0.005 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.896082e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.897842e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.898672e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.907749e-01 | 0.004 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.915197e-01 | 0.004 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.916696e-01 | 0.004 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.922411e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.924775e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.924775e-01 | 0.003 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.924855e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.924855e-01 | 0.003 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.932072e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.932072e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.936810e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.936810e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.938661e-01 | 0.003 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.945775e-01 | 0.002 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.948189e-01 | 0.002 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.949985e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.949985e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.949985e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.954712e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.954837e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.958621e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.969976e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.969976e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.971204e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.971204e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.975521e-01 | 0.001 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.977897e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.978548e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.980003e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.981721e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.983782e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.984807e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.984807e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.986457e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.986735e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989186e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.989932e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.990762e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.991184e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.991994e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.993377e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993511e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.995224e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.995688e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.996486e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996827e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997007e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997135e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997217e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.997669e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998068e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.998071e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998148e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998600e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998716e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998859e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999695e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999701e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999819e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999819e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999853e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999854e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999897e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999905e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999912e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999924e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999928e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999953e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999957e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999963e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999965e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999973e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999975e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999976e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999991e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999992e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999992e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999993e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999994e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |